Skip to main content
Advertisement
  • Loading metrics

The polyadenylase PAPI is required for virulence plasmid maintenance in pathogenic bacteria

  • Katherine Schubert,

    Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft

    Affiliation Department of Molecular, Cell, and Developmental Biology, UC Santa Cruz, Santa Cruz, California, United States of America

  • Jessica Zhang,

    Roles Formal analysis, Investigation, Methodology, Visualization, Writing – review & editing

    Affiliations Department of Biology, Stanford University, Stanford, California, United States of America, Sarafan ChEM-H Institute, Stanford University, Stanford, California, United States of America

  • Michele E. Muscolo,

    Roles Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – review & editing

    Affiliations Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, United States of America, Tufts Stuart B Levy Center for Integrated Management of Antimicrobial Resistance, Tufts University, Boston, Massachusetts, United States of America

  • Micah Braly,

    Roles Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization

    Affiliation Department of Microbiology and Environmental Toxicology, UC Santa Cruz, Santa Cruz, California, United States of America

  • Joshua W. McCausland,

    Roles Data curation, Formal analysis, Software, Visualization, Writing – review & editing

    Affiliations Department of Biology, Stanford University, Stanford, California, United States of America, Sarafan ChEM-H Institute, Stanford University, Stanford, California, United States of America, Howard Hughes Medical Institute, Stanford University, Stanford, California, United States of America

  • Hanh N. Lam,

    Roles Data curation, Formal analysis, Methodology

    Affiliation Department of Microbiology and Environmental Toxicology, UC Santa Cruz, Santa Cruz, California, United States of America

  • Karen Hug,

    Roles Investigation, Visualization

    Affiliation Department of Microbiology and Environmental Toxicology, UC Santa Cruz, Santa Cruz, California, United States of America

  • Matthew Loven,

    Roles Investigation

    Affiliation Department of Microbiology and Environmental Toxicology, UC Santa Cruz, Santa Cruz, California, United States of America

  • Santiago Ruiz Solis,

    Roles Investigation, Visualization

    Affiliation Department of Microbiology and Environmental Toxicology, UC Santa Cruz, Santa Cruz, California, United States of America

  • Melissa Estrada Escobar,

    Roles Investigation

    Affiliation Department of Microbiology and Environmental Toxicology, UC Santa Cruz, Santa Cruz, California, United States of America

  • Henry Moore,

    Roles Data curation, Visualization

    Affiliation Department of Biomolecular Engineering, UC Santa Cruz, Santa Cruz, California, United States of America

  • Derfel Terciano,

    Roles Data curation, Formal analysis, Visualization

    Affiliation Department of Microbiology and Environmental Toxicology, UC Santa Cruz, Santa Cruz, California, United States of America

  • Diana Fernandez Pacheco,

    Roles Validation

    Affiliation Department of Microbiology and Environmental Toxicology, UC Santa Cruz, Santa Cruz, California, United States of America

  • Todd M. Lowe,

    Roles Software, Supervision

    Affiliation Department of Biomolecular Engineering, UC Santa Cruz, Santa Cruz, California, United States of America

  • Cammie F. Lesser,

    Roles Funding acquisition, Methodology, Project administration, Supervision, Writing – original draft, Writing – review & editing

    Affiliations Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, United States of America, Tufts Stuart B Levy Center for Integrated Management of Antimicrobial Resistance, Tufts University, Boston, Massachusetts, United States of America

  • Christine Jacobs-Wagner,

    Roles Funding acquisition, Project administration, Supervision, Writing – original draft, Writing – review & editing

    Affiliations Department of Biology, Stanford University, Stanford, California, United States of America, Sarafan ChEM-H Institute, Stanford University, Stanford, California, United States of America, Howard Hughes Medical Institute, Stanford University, Stanford, California, United States of America, Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, United States of America

  • Helen Wang,

    Roles Investigation, Methodology, Resources, Validation, Writing – review & editing

    Affiliation Department of Medical Biochemistry and Microbiology, Uppsala Universitet, Uppsala, Sweden

  •  [ ... ],
  • Victoria Auerbuch

    Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Methodology, Project administration, Resources, Supervision, Visualization, Writing – original draft, Writing – review & editing

    vastone@ucsc.edu

    Affiliation Department of Microbiology and Environmental Toxicology, UC Santa Cruz, Santa Cruz, California, United States of America

  • [ view all ]
  • [ view less ]

Abstract

Many species of pathogenic bacteria harbor critical plasmid-encoded virulence factors, and yet the regulation of plasmid replication is often poorly understood despite playing a key role in plasmid-encoded gene expression. Human pathogenic Yersinia, including the plague agent Yersinia pestis and its close relative Y. pseudotuberculosis, require the type III secretion system (T3SS) virulence factor to subvert host defense mechanisms and colonize host tissues. The Yersinia T3SS is encoded on the IncFII plasmid for Yersinia virulence (pYV). Several layers of gene regulation enable a large increase in expression of Yersinia T3SS genes at mammalian body temperature. Surprisingly, T3SS expression is also controlled at the level of gene dosage. The number of pYV molecules relative to the number of chromosomes per cell, referred to as plasmid copy number, increases with temperature. The ability to increase and maintain elevated pYV plasmid copy number, and therefore T3SS gene dosage, at 37˚C is important for Yersinia virulence. In addition, pYV is highly stable in Yersinia at all temperatures, despite being dispensable for growth outside the host. Yet how Yersinia reinforces elevated plasmid replication and plasmid stability remains unclear. In this study, we show that the chromosomal gene pcnB encoding the polyadenylase PAP I is required for regulation of pYV plasmid copy number (PCN), maintenance of pYV in the bacterial population outside the host, robust T3SS activity, and Yersinia virulence in a mouse infection model. Likewise, pcnB/PAP I is required for robust expression of the Shigella flexneri T3SS that, similar to Yersinia, is encoded on a virulence plasmid whose replication is regulated by sRNA. Furthermore, Yersinia and Shigella pcnB/PAP I is required for maintaining model antimicrobial resistance (AMR) plasmids whose replication is regulated by sRNA, thereby increasing antibiotic resistance by ten-fold. These data suggest that pcnB/PAP I contributes to the spread and stabilization of sRNA-regulated virulence and AMR plasmids in bacterial pathogens, and is essential in maintaining the gene dosage required to mediate plasmid-encoded traits. Importantly pcnB/PAP I has been bioinformatically identified in many species of bacteria despite being studied in only a few species to date. Our work highlights the potential importance of pcnB/PAP I in antibiotic resistance, and shows for the first time that pcnB/PAP I promotes virulence plasmid stability in natural pathogenic hosts with a direct impact on bacterial virulence.

Author summary

Many pathogens carry extrachromosomal DNA elements known as plasmids, which encode genes that confer bacterial virulence or antimicrobial resistance (AMR). Acquisition of these plasmids by bacteria can lead to the emergence of new pathogenic traits and the spread of AMR, yet the mechanisms by which plasmids are retained in bacterial populations, particularly in the absence of selective pressure, remain incompletely understood. Here we show that the major bacterial polyadenylase enzyme PAP I, encoded by the pcnB gene, is critical for the human pathogens Yersinia pseudotuberculosis and Shigella flexneri to maintain their native virulence plasmids as well as AMR plasmids. Very little is known about the process of polyadenylation in bacteria, or the post-transcriptional addition of adenosine residues to the 3’ end of transcripts. This study suggests that PAP I-mediated polyadenylation may contribute to plasmid-mediated virulence and AMR.

Introduction

Many species of pathogenic bacteria harbor plasmids that encode genes important for virulence or antimicrobial resistance (AMR). Virulence plasmids are typically characterized by their relatively large size (>40kb) and low plasmid copy number (PCN), which refers to the average number of plasmid copies per cell or chromosome equivalent [1]. In addition to virulence or AMR genes, these plasmids typically contain additional genes important for plasmid replication, PCN control, and plasmid stability. Virulence plasmids are commonly found in members of the Enterobacteriaceae family, which includes several species of Gram-negative pathogens. For example, Yersinia pseudotuberculosis and the related plague agent Yersinia pestis naturally harbor a ~ 70 kb low copy number virulence plasmid known as the plasmid for Yersinia virulence (pYV), also called pCD1 in Y. pestis [24]. Given that Y. pestis has killed over 200 million people since antiquity [5], pYV has played a grim but important role in human history.

The pYV plasmid encodes several factors important for Yersinia virulence, including a major virulence factor known as the type III secretion system (T3SS) [68]. The T3SS is used to inject a series of effector proteins known as Yersinia outer proteins (Yops) directly into the cytosol of target host cells during infection. Yops dampen the host immune response and promote Yersinia pathogenesis, making pYV essential for Yersinia virulence [3,913]. Expression and activity of the T3SS exerts a metabolic burden on the bacteria. Therefore, Yersinia repress expression of the T3SS at low environmental temperatures when the T3SS is dispensable, but induce T3SS expression at mammalian body temperature, 37°C [1419]. Several mechanisms contribute to this temperature dependency. For example, the master regulator of the T3SS is only translated at 37°C due to control by an RNA thermometer [18,20]. More recently, it was reported that temperature-dependent changes in T3SS gene expression is also regulated at the level of gene dosage via changes in pYV PCN [21]. At environmental temperatures such as 26°C, pYV PCN has been reported to be low (~1–2 copies per chromosome). Upon exposure to mammalian temperatures of 37°C, pYV PCN has been shown to be rapidly upregulated to 3 + copies per chromosome. Importantly, this ability to upregulate pYV PCN and T3SS gene dosage is essential for normal T3SS activity and Y. pseudotuberculosis virulence [21,22]. Dynamic changes in pYV PCN and retention of the pYV plasmid during these rapid changes are therefore required for the Y. pseudotuberculosis pathogenic lifestyle.

The pYV plasmid encodes several systems important for plasmid regulation and maintenance, including a cop-rep locus that regulates plasmid replication, a ParABS partitioning system that ensures each daughter cell inherits the plasmid, and a ParDE toxin-antitoxin (TA) system that promotes plasmid maintenance in the bacterial population [1,23]. Together, these systems are predicted to synergistically enforce plasmid stability, or the percentage of cells in the population that maintain the plasmid. The highly conserved cop-rep locus places pYV in the IncFII group of plasmids [1,24,25]. The cop-rep locus encodes the essential replication initiation factor RepA, which binds to and melts the plasmid origin of replication, and two negative regulators of RepA expression: the CopA small RNA (sRNA) and the CopB protein. The functions of RepA, CopA, and CopB have been elucidated using plasmid R1, an IncFII plasmid originally isolated from a clinical strain of Salmonella enterica that has been extensively studied in Escherichia coli model systems [2527]. These studies support the notion that CopA and CopB regulate the rate of plasmid replication to minimize fluctuations above or below the average PCN set-point [25,28].

Using Y. pseudotuberculosis as a model, we identified the chromosomal pcnB gene as a previously unknown regulator of pYV replication and stability. The pcnB gene was named for plasmid copy number B since loss of pcnB was found to decrease PCN for several model plasmids in E. coli [29,30]. The pcnB gene encodes the poly A polymerase (PAP I), the major bacterial polyadenylase ubiquitous in β- and γ-proteobacteria [2936]. Polyadenylation, or the addition of adenosine residues to the 3’ OH of an RNA transcript, is poorly understood in bacteria compared to eukaryotes. In E. coli, polyadenylation promotes decay of RNA transcripts with structured 3’ ends. The 3’-5’ exonucleases PNPase and RNase II inefficiently digest RNA with secondary structure at their 3’ ends, such as those found in sRNA [3739]. PAP I adds poly(A) tails to these RNAs, providing a “toe-hold” for PNPase and RNase II and potentiating RNA decay [40]. PAP I-mediated polyadenylation promotes RNA degradation as part of a housekeeping mechanism [41], but polyadenylation is also implicated in certain gene regulatory networks [4247]. PAP I-dependent polyadenylation has been shown to destabilize RNAs that negatively regulate replication of certain plasmid types in E. coli, including CopA from plasmid R1 and RNAI from ColE1 plasmids [29,4851]. RNAI is an antisense RNA that blocks the R-loop formation necessary for ColE1 plasmid replication initiation [52]. However, PAP I has not been studied in the context of a naturally occurring virulence or AMR plasmid within its native host, and has never been linked to bacterial virulence.

Here, we report that Y. pseudotuberculosis pcnB mutants display reduced PCN and decreased stability of pYV. These defects are associated with reduced T3SS activity in bacterial culture and impaired virulence in a mouse infection model. Furthermore, we show that pcnB is required for normal T3SS expression in the pathogen Shigella flexneri, which also harbors a virulence plasmid encoding a T3SS. Lastly, Y. pseudotuberculosis and S. flexneri require pcnB to maintain model AMR plasmids belonging to various plasmid families, highlighting a role for the pcnB gene in plasmid-mediated virulence and AMR.

Results

Y. pseudotuberculosis toggles pYV plasmid copy number in response to temperature

To determine the average PCN per chromosome equivalents at the bacterial population level, we used droplet digital (dd)PCR to measure the number of pYV molecules relative to chromosomes in wildtype Y. pseudotuberculosis IP2666pIB1 [22]. Cells were either grown at 26°C to represent growth in environmental conditions outside of the host or at 37°C in low calcium media to represent host cell contact during mammalian infection. The pYV-encoded T3SS is expressed at 37°C and becomes active for secretion following host cell membrane contact or calcium chelation [5356]. Consistent with previous studies [21,22], we observed an increase in pYV PCN from an average of ~1.5 pYV copies per chromosome equivalents at 26°C to ~3 copies at 37°C/low calcium (Fig 1A). In addition, using a YPIII/pIBX strain of Y. pseudotuberculosis harboring a pYV-encoded luciferase reporter, we found that relative pYV-encoded luciferase activity normalized to cell density increases one hour after shifting the cultures to 37°C/low calcium conditions (Fig 1B). As luciferase gene dosage correlates with bioluminescence [21], these data support the conclusion that pYV PCN increases at 37˚C.

thumbnail
Fig 1. Y. pseudotuberculosis pYV plasmid copy number (PCN) dynamically changes in response to temperature.

(A) pYV PCN per chromosome was determined for wildtype Y. pseudotuberculosis IP2666pIB1 grown at 26°C or 37°C/low calcium using droplet digital PCR (dd)PCR, as the ratio between concentrations of pYV and chromosome DNA. (B) Relative pYV plasmid copy number of wildtype Y. pseudotuberculosis YPIII/pIBX was determined following growth at 26°C or 37°C/low calcium using a luciferase reporter stably incorporated in the pIBX plasmid, normalized to bacterial cell density (OD600). ODU, optical density units. (A-B) Averages of three independent experiments are shown ± standard error of the mean (Student t-test, *** p < 0.001, * p < 0.05). (C) Representative phase contrast (left) and fluorescence (right) images of Y. pseudotuberculosis YPIII/pIBX cells where the pYV plasmid is visualized using a ParB-msfGFP fluorescent marker. Images are shown for cells grown at 26°C or under the 37°C/low calcium condition. (D) Histogram depicting the number of ParB-msfGFP-labeled puncta of pYV quantified from data illustrated in panel C. Three biological replicates per condition were imaged and analyzed; for each strain and condition, between 790–4428 cells were analyzed per replicate.

https://doi.org/10.1371/journal.ppat.1012655.g001

To examine pYV PCN at the single-cell level, we employed a microscopy-based approach. To visualize and quantify pYV puncta in living Y. pseudotuberculosis cells, we generated a YPIII/pIBX Y. pseudotuberculosis strain that harbors a parB-msfGFP translational fusion in the native parB pYV locus. This approach has been used to visualize plasmids in other bacterial species [57,58], as ParB binds to plasmid-encoded parS sequences but has never been used to study pYV in Y. pseudotuberculosis. At 26°C, cells were found to have an average of about four pYV puncta per cell (Fig 1C-D). This number increased to an average of about seven puncta per cell by 1.5 hours after the shift to 37°C (Fig 1C-D). The higher number of pYV per cell than per chromosome equivalents (Figs 1D vs. 1A) is consistent with the expectation that Yersinia has more than one chromosome per cell on average under nutrient-rich (fast) growth conditions, similar to E. coli [59,60]. Regardless of the normalization method (per cell or chromosome), Yersinia pYV PCN consistently increased by ~1.5-fold upon shifting bacterial cultures from 26°C to 37°C/low calcium conditions. The pYV plasmid was highly stable, with the vast majority of cells retaining pYV in Y. pseudotuberculosis (Fig 1D).

Disruption of the pcnB gene encoding the polyadenylase PAP I decreases pYV PCN and T3SS expression

In a screen for genes that regulate the Yersinia T3SS, we identified a novel factor that appeared to regulate pYV replication. Y. pseudotuberculosis with a functional T3SS, but lacking T3SS Yop effectors (∆yop6), induces activation of the transcription factor NFκB in mammalian cells [61]. The LPS metabolite ADP heptose is delivered to the host cell cytoplasm through the T3SS, stimulating Alpk1/TIFA-dependent NFκB activation [62], although YopJ inhibits NFκB signaling [63,64]. We used human embryonic fibroblast cells, HEK293T, expressing an NFκB luciferase reporter to identify a Y. pseudotuberculosis IP2666pIB1 ∆yop6 transposon (Tn) mutant that induced elevated bioluminescence compared to the parental strain, ∆yop6/pil::Tn (S1A Fig) [61]. This mutant was found to harbor a Tn insertion in a previously unannotated locus adjacent to the highly conserved pYV cop-rep locus. We will refer to this locus as the plasmid inhibitory locus (pil) (S1B Fig). Given the location of the pil locus relative to cop-rep, we hypothesized that this transposon insertion affects the pYV PCN. To test this, we introduced the pil::Tn insertion mutation into a clean wildtype Y. pseudotuberculosis IP2666pIB1 strain background with intact T3SS effector Yop-encoding genes (referred to as the pil::Tn mutant). Consistent with our hypothesis, the pil::Tn mutant displayed elevated secretion of T3SS cargo proteins compared to wildtype Yersinia (S1C Fig). In addition, we constructed a mutant in the YPIII/pIBX background with a plasmid insertion into the same locus in pil (pil::pNQ). As expected, the pil::Tn and pil::pNQ strains had elevated pYV PCN at 26°C and early after shifting to 37°C relative to the parental strain (S1D, E Fig), which is likely the underlying cause of the increased T3SS activity.

Insertion into the pil locus was associated with poor growth compared to the parental strain under T3SS-inducing conditions, and suppressor mutants could be readily isolated (S1F Fig). We hypothesized that constitutively elevated pYV PCN contributed to this growth defect, resulting in selective pressure favoring suppressor mutations that would alleviate high pYV PCN. Therefore, we used the pil::pNQ mutation as a tool to identify genes important for pYV PCN homeostasis. We carried out whole genome sequencing of a subset of pil::pNQ suppressor mutants and identified several categories of mutations affecting growth, pYV PCN, and the T3SS (S1 Table). Two clones harbored a single point mutation that was associated with reduced pYV PCN and T3SS activity relative to the pil::pNQ parental strain. This mutation was mapped to the pcnB gene encoding the polyadenylase PAP I, and was predicted to confer a leucine to arginine change at position 291 (L291R) in the PAP I neck domain linked to RNA binding (S2A Fig). The L291 residue is conserved in PAP I from E. coli, suggesting that the residue might be important for PAP I structure and/or function (S2A Fig). We will use the term pcnB when referring to the gene, and PAP I when referring to the pcnB-encoded protein.

To confirm that the pcnB gene encoding PAP I affects Y. pseudotuberculosis pYV PCN, we generated a full in-frame deletion of the pcnB gene (∆pcnB) in the wildtype and pil::Tn IP2666pIB1 strain backgrounds. We used ddPCR to measure relative pYV PCN and found that compared to wildtype, the ∆pcnB mutant had lower pYV PCN following growth at 26°C and 37°C/low calcium (Fig 2A). In keeping with our previous findings, the pil::Tn mutant displayed significantly higher pYV PCN at 26°C compared to wildtype. Furthermore, loss of PAP I in the pil::Tn/pcnB double mutant significantly reduced pYV PCN at 26°C compared to the pil::Tn parental strain. These results show that loss of pcnB leads to decreased pYV PCN. Despite this, loss of pcnB did not prevent Yersinia from increasing pYV PCN upon shift from 26°C to 37°C, although not to the same high PCN as in wildtype (Fig 2A). Consistent with this reduction in T3SS gene dosage, the ∆pcnB mutant displayed two-fold less expression and secretion of the T3SS effector protein YopE compared to wildtype Y. pseudotuberculosis (Fig 2B, C). Similarly, pcnB deletion reduced YopE expression and secretion in the pil::Tn strain background (Fig 2B, C). Taken together, these data suggest that pcnB contributes to maintaining pYV PCN, which in turn promotes robust T3SS expression under T3SS-inducing conditions.

thumbnail
Fig 2. Disruption of the pcnB gene encoding poly(A) polymerase PAP I decreases pYV PCN as well as T3SS expression and activity.

(A) pYV plasmid copy number per chromosome was determined for Y. pseudotuberculosis IP2666pIB1 strains grown at 26°C or 37°C/low calcium using ddPCR. Averages of three independent experiments are shown ± standard error of the mean. Statistical significance was performed using a one-way ANOVA with Tukey’s multiple comparisons test (**** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05). (B) Y. pseudotuberculosis IP2666pIB1 strains were grown in low calcium media at 37°C before preparing samples for western blotting. Bacterial pellets (P) were collected and secreted proteins (Yops) were precipitated from the supernatant (S). Images shown represent a single blot that was independently probed for YopE and RpoA, which serves as a loading control. (C) YopE pellet protein levels were quantified by densitometry relative to RpoA. Averages ± standard error of the mean are shown for three independent experiments. Statistical analysis was performed using a one-way ANOVA with Tukey’s multiple comparisons test (** p < 0.01, ** p < 0.001).

https://doi.org/10.1371/journal.ppat.1012655.g002

To determine how the pcnB gene and the pil::Tn disruption broadly impact expression of pYV-encoded genes, we carried out RNA-seq analyses on wildtype, ∆pcnB, pil::Tn, and pil::Tn/pcnB Y. pseudotuberculosis IP2666pIB1 grown at 26°C and 37°C/low calcium (S1 Data, GEO series accession number GSE292107). Most pYV-encoded gene transcripts were present at higher steady-state level in the pil::Tn mutant compared to wildtype Y. pseudotuberculosis at both temperatures (S3 Fig), consistent with an increase in pYV gene dosage. However, T3SS genes are not translated at 26°C due to the action of several RNA thermometers in Yersinia [53], and the pil::Tn strain does not display T3SS activity at 26˚C despite elevated T3SS gene transcripts at this temperature (S4 Fig). Interestingly, the pil::Tn strain displayed an altered RNA-Seq read pattern mapping to the pil-copB-repA locus at both temperatures (S5 Fig). We observed no difference in pYV PCN or T3SS expression when we generated a full in-frame deletion of the predicted ORF found in the pil locus (S1C, S1E Fig). Therefore, we propose that Tn or pNQ insertion into pil leads to derepressed transcription of the cop-rep locus leading to elevated pYV replication through an as-yet unknown mechanism. In contrast, deletion of pcnB resulted in fewer transcripts of most pYV-encoded genes compared to wildtype Yersinia at both temperatures (S3 Fig), consistent with a decrease in pYV gene dosage. In addition, pcnB deletion in the pil::Tn background also led to a decrease in the steady-state levels of most T3SS genes compared to the pil::Tn parental strain (S3 Fig). We conclude that loss of pcnB leads to a decrease in pYV PCN in both the wildtype and pil::Tn backgrounds, leading to decreased transcription of pYV-encoded genes and mitigation of T3SS activity-induced growth arrest.

PAP I is required for pYV stability

When working with the ∆pcnB strain, we noted that cells lost the pYV plasmid at a higher rate than observed with wildtype Y. pseudotuberculosis (Table 1). To determine whether PAP I affects pYV stability in addition to pYV PCN, we generated a ∆pcnB strain in the ParB-msfGFP YPIII/pIBX Y. pseudotuberculosis background. We observed ∆pcnB cells with lower cellular GFP fluorescence and lacking clear fluorescent foci, consistent with plasmid loss (Fig 3A). The presence of these plasmid-devoid cells in the ∆pcnB strain resulted in a clear bimodal distribution of cellular fluorescence (Fig 3B), showing that ~34% of ∆pcnB cells displayed low cellular fluorescence compared to only ~3% for the parental strain population at the time of imaging at 26ºC (p < 10-100, Kolmogorov-Smirnov (KS) test; n = 7,033 cells per strain). The ∆pcnB mutant also had a high percentage (24%) of cells with low cellular fluorescence under the 37°C/low calcium condition (Fig 3B). The majority of cells with low cellular fluorescence had no detectable pYV spots (S6 Fig). By analyzing only those cells that retained at least one copy of pYV, we found that the ∆pcnB mutant showed the expected increase in ParB-msfGFP puncta per cell from 26°C to 37°C/low calcium (Fig 3C). However, the ∆pcnB distributions were significantly shifted toward lower values relative to the parental strain (p < 10-100; Fig 3D, E). While the parental strain had, on average, 4.5 and 7.9 pYV spots per cell at 26˚C and 37˚C/low calcium, respectively, the ∆pcnB strain had 3.9 and 6.3. Thus, the pcnB gene does not affect the ability of the cells to respond to the T3SS-inducing environmental shift, but its loss leads to lower average PCN as well as increased frequency of plasmidless Yersinia cells. It is likely that the T3SS expression defect seen in the ∆pcnB mutant (Fig 2B, C) is due to an overall decrease in pYV burden in the bacterial population.

thumbnail
Table 1. PAP I is required for pYV maintenance in Y. pseudotuberculosis.

https://doi.org/10.1371/journal.ppat.1012655.t001

thumbnail
Fig 3. The pcnB gene is required for maintenance of the pYV plasmid.

(A) Representative phase contrast (left) and fluorescence (right) images of Y. pseudotuberculosis YPIII/pIBX ∆pcnB cells where the pYV plasmid is visualized using a ParB-msfGFP fluorescent marker. Images are shown for cells grown at 26°C or under the 37°C/low calcium condition. White arrowheads indicate cells with low fluorescence signal and no puncta, suggesting that they lack plasmids. (B) Histograms comparing the fluorescence intensity of ParB-msfGFP in the parental strain and ∆pcnB cells under 26°C or 37°C/low calcium conditions. Mean fluorescence intensity values are plotted on the x-axis (log10). Shaded error bars represent the mean ± standard error of the mean from bootstrapping the data 100 times. Both histograms were randomly sampled without replacement to match the lowest n value of either condition (7,033 and 10,003 for the 26ºC and 37ºC/low calcium conditions, respectively). Both distributions are significantly different (p < 10-100) based on the Kolmogorov-Smirnov test. A.U. indicates arbitrary units. (C) Histograms depicting the number of ParB-msfGFP-labeled puncta of pYV quantified from data illustrated in panel A. Only cells with at least one detected pYV spot were considered. Three biological replicates were imaged and analyzed per condition. For each strain and condition, between 2063 to 14,479 cells were analyzed per replicate. 26˚C, pink; 37˚C/low calcium, blue. (D) Same as (C) except that the comparison is between the parent and ∆pcnB strains grown at 26°C. For each strain and condition, between 760 to 4179 cells were analyzed per replicate. (E) Same as (D) except that it is for the 37°C/low calcium condition. For each strain and condition, between 2046 to 14,479 cells were analyzed per replicate. Distributions in panels D and E are significantly different (p < 10-80) by Kolmogorov-Smirnov tests.

https://doi.org/10.1371/journal.ppat.1012655.g003

To further examine the extent of the pYV plasmid stability defect in the ∆pcnB mutant, we passaged bacteria on solid media for several days at 26°C and then assessed pYV retention for each clone by patching onto low calcium media containing the dye Congo red, and incubating at 37˚C. Congo red only binds to bacterial colonies that are expressing a functional T3SS [65]. Wildtype cells retained the pYV plasmid at 100% while the ∆pcnB mutant cells only retained pYV in 82% of cells following incubation at 26˚C for 16 hours (Table 1). When cells were exposed to T3SS-inducing conditions at 37°C/low calcium and returned to 26°C to mimic the Y. pseudotuberculosis facultative lifecycle, we found that only 58% of ∆pcnB cells retained pYV compared to 99% for wildtype (Table 1). This observed increase in pYV loss likely stems from the growth arrest of pYV+ clones specifically under T3SS-inducing conditions at 37˚C [15,54,55], which provides a selective growth advantage for ∆pcnB clones that have lost pYV. Altogether, these data support a role for PAP I in regulation of pYV PCN and plasmid stability during the Y. pseudotuberculosis facultative lifecycle.

The PAP IL291R mutation affects PAP I protein levels

The original pcnB suppressor mutation identified in our pil::Tn suppressor screen was a single point mutation that changed leucine in position 291 to an arginine (L291R) (S2 Fig). Although the corresponding L291 residue is conserved in E. coli, it has not yet been identified as a critical PAP I residue. Thus, as a first step in investigating the role of this residue, we assessed whether the L291R mutation affects PAP I expression. We introduced the L291R missense mutation into the native pcnB locus of both Y. pseudotuberculosis IP2666pIB1 (with or without a PAP I C-terminal FLAG tag) and YPIII/pIBX to generate PAP IL291R strains. We found that the PAP IL291R protein was poorly expressed, particularly at 37°C/low calcium (Figs 4A and S7). These data suggest that the PAP IL291R allele may be unstable, leading to low PAP I expression at least at 37°C/low calcium. Interestingly, a strain engineered with a more conservative leucine to alanine mutation at position 291, PAP IL291A, did not significantly affect PAP I expression levels (Figs 4A and S7). Consistent with these data, the PAP IL291R mutant showed enhanced loss of pYV compared to the wildtype strain or the PAP IL291A mutant, as indicated by the emergence of white, fast-growing colonies following growth under 37°C/low calcium conditions on Congo red agar (Fig 4B). Interestingly, the PAP IL291R strain displayed a greater loss of pYV following long passage at 37°C/low calcium compared to when bacteria were passaged at 26°C (Table 2), reflective of the normal PAP IL291R protein steady-state levels at 26˚C compared to 37˚C. Consistently, the PAP IL291R strain had significantly lower average pYV PCN compared to the wildtype and PAP IL291A strains at 37˚C/low calcium (Fig 4C), and this correlated with lower relative T3SS activity (Fig 4D). Structure modeling of Yersinia PAP I suggests that the L291 residue is not surface exposed (S2C Fig). Our data suggest that mutation of the L291 residue to an arginine, but not an alanine, disrupts PAP I protein levels, explaining why we identified the L291R mutation in our suppressor screen.

thumbnail
Table 2. Predicted PAP I catalytic residues are required for stability of the pYV plasmid.

https://doi.org/10.1371/journal.ppat.1012655.t002

thumbnail
Fig 4. PAP I point mutations lead to a decrease in pYV PCN, plasmid stability, and T3SS activity.

(A) Y. pseudotuberculosis IP2666pIB1 strains harboring various PAP IFLAG alleles grown at 26°C or 37°C/low calcium were pelleted and prepared for western blot analyses. Images shown represent a single blot that was cut after transferring and independently probed for expression of PAP IFLAG (top) and RpoA (loading control, bottom). Data shown is representative of three biological replicates, with the averaged data shown in S7 Fig. (B) Y. pseudotuberculosis IP2666pIB1 strains were grown at 26°C before diluting and spotting onto either LB or low calcium plates containing Congo red dye and incubated at 26°C or 37°C, respectively, prior to imaging. The black arrow points to an example white colony indicative of plasmid loss and concomitant faster growth. Black box shows an example lawn of slow-growing bacteria harboring pYV and so therefore taking up the Congo red dye. (C) Relative pYV plasmid copy number was estimated for strains in the Y. pseudotuberculosis pIBX/YPIII background. For each timepoint, luminescence was measured and normalized to cell density (OD600). Averages of three independent experiments are shown ± standard error of the mean. Each strain per condition was compared to the wildtype strain in a one-way ANOVA with Dunnett’s multiple comparisons test (*** p < 0.005, ** p < 0.01, * p < 0.05). (D) Y. pseudotuberculosis IP2666pIB1 strains were grown at 37°C/low calcium and secreted proteins in the supernatant fractions were precipitated and visualized after separation on as SDS-PAGE gel by Coomassie blue staining. Bovine serum albumin (BSA) was used as a protein precipitation control. The YopE T3SS effector protein band from four independent experiments was visualized, quantified, and normalized to BSA from the same samples. Averages ± standard error of the mean are shown. Statistical significance was determined using an unpaired t test (** p < 0.005, * p < 0.05).

https://doi.org/10.1371/journal.ppat.1012655.g004

Mutation of residues predicted to affect polyadenylase activity decreases pYV PCN, plasmid stability, and T3SS activity

PAP I D80 and D82 have been shown to be essential for PAP I polyadenylase catalytic activity in E. coli [66,67]. These residues are also present in Y. pseudotuberculosis PAP I (S2 Fig). To determine whether these catalytic residues are important for normal pYV PCN and stability, we mutated the two corresponding aspartic acid residues (D114 and D116) to alanine to produce a PAP ID2A catalytic mutant. As expected, the D2A mutation did not affect PAP I steady state protein levels (Figs 4A, and S7) yet displayed the same level of reduced pYV PCN as the ∆pcnB strain that lacks PAP I completely (Fig 4C). Spot test serial dilution analyses found that PAP ID2A grows similarly to wildtype and ∆pcnB at 26°C (Fig 4B). Furthermore, at 37°C/low calcium, PAP ID2A and ∆pcnB exhibited about 10-fold more growth compared to wildtype (Fig 4B), consistent with a reduction in growth arrest due to decreased T3SS activity. Similarly, the strain expressing PAP ID2A, like the ∆pcnB mutant, displayed an increased number of plasmidless, rapidly-growing colonies (Fig 4B) and reduced pYV stability (Table 2). Lastly, the PAP ID2A allele did not support normal T3SS activity (Fig 4D). Taken together, these data suggest that Yersinia PAP I residues predicted to be required for polyadenylase activity are necessary to maintain normal pYV PCN, plasmid stability, and T3SS gene expression and activity.

Yersinia PAP I is required for plasmid stability and plasmid-mediated antibiotic resistance from a broad range of plasmid families

To determine if Yersinia PAP I contributes to regulation of PCN and retention of other plasmid types, we introduced a ColE1-like pGFP-uv plasmid into wildtype and ∆pcnB Y. pseudotuberculosis. This plasmid lacks active partitioning systems such as ParABS, but can be maintained within the population by antibiotic resistance selection [68]. We observed a decrease in fluorescence intensity of ∆pcnB colonies, as well as ~10-fold less plating efficiency of the ∆pcnB strain, when grown on carbenicillin-containing media compared to wildtype (Fig 5A). In addition, we found that over 70% of ∆pcnB cells lack the pGFP-uv plasmid within 10 hours of removing carbenicillin and the plasmid is completely lost from the population by ~36 hours. In contrast, 100% of wildtype cells retained pGFP-uv over the same 36 hour time course (Fig 5B). These data suggest that loss of PAP I activity attenuates GFP expression, plasmid stability, and plasmid-encoded β-lactam resistance in Yersinia harboring the ColE-like pGFPuv plasmid.

thumbnail
Fig 5. The pcnB gene is required for plasmid-mediated antibiotic resistance in Y. pseudotuberculosis.

(A) Wildtype and ∆pcnB Y. pseudotuberculosis IP2666pIB1 harboring pGFP-uv were spotted simultaneously onto either plain LB plates or LB plates containing carbenicillin to assess retention of pGFP-uv. Plates were incubated at 26°C for ~16 hrs before imaging spots under a GFP filter. (B) Retention of the pGFP-uv plasmid by wildtype and ∆pcnB Y. pseudotuberculosis IP2666pIB1 was assessed at 26°C over 40 hrs following the removal of carbenicillin. (C) Wildtype and ∆pcnB Y. pseudotuberculosis IP2666pIB1 harboring either no vector, a pTrc99::empty vector control, or a pTrc99::PAP I recombinant plasmid were spotted onto either plain LB plates or LB plates containing carbenicillin to select for pTrc99 and 0.2 mM IPTG to induce PAP I expression. Plates were incubated at 26°C for ~16 hrs prior to imaging. (D) Wildtype and ∆pcnB Y. pseudotuberculosis IP2666pIB1 harboring either no vector or a pNF06 mini-F plasmid with a ccdAB TA system (pNF06::ccdAB) were spotted onto either plain LB plates or LB plates containing 25 µg/mL kanamycin to select for pNF06. Plates were incubated at 26°C for ~16 hrs prior to imaging.

https://doi.org/10.1371/journal.ppat.1012655.g005

To ensure that the reduced plating efficiency on antibiotics seen for ∆pcnB harboring pGFP-uv was due to loss of PAP I specifically, we next constructed a PAP I overexpression plasmid in the pTrc99 vector backbone. Importantly, pTrc99 is also a ColE1-like plasmid that lacks partitioning systems [69]. We found that ∆pcnB harboring pTrc99::empty displays 10-fold less plating efficiency when spotted onto LB-carbenicillin but not LB-only plates (Fig 5C), consistent with what we previously observed with the pGFP-uv plasmid. Importantly, this decreased plating efficiency was nearly completely abolished by expression of PAP I from the pTrc99 plasmid (Fig 5C). In addition to ColE1 plasmids, we found that PAP I is also required for robust antibiotic resistance conferred by plasmids with p15A-like origins of replication (pACYC184, pBAD33) (S8 Fig). Interestingly, replication of plasmids containing ColE-like and p15A-like origins of replication, as well as IncFII plasmids like pYV, is regulated by plasmid-specific sRNA [7072], suggesting a general role for PAP I in regulating plasmids with replicons regulated by a sRNA. To test if loss of pcnB would affect antibiotic resistance conferred by a plasmid whose replication is not known to be regulated by a sRNA, we introduced the mini-F plasmid pNF06::ccdAB into wildtype and ∆pcnB Y. pseudotuberculosis [30,48,73,74]. The ∆pcnB strain displayed equal plating efficiency to the wildtype strain in the presence of antibiotic selection, suggesting that pNF06::ccdAB maintenance is likely not affected by PAP I (Fig 5D). These data suggest that PAP I is important in Yersinia for normal maintenance of plasmids whose replication is regulated by a sRNA.

PAP I is required for Y. pseudotuberculosis virulence in mice

It is well established that the pYV plasmid and T3SS are critical for Y. pseudotuberculosis virulence in mouse infection models [6,75]. To determine if loss of PAP I contributes to Yersinia virulence, we infected mice via the intraperitoneal (IP) route and monitored colonization of the spleen and liver. Four days post-inoculation, significantly fewer ∆pcnB-infected mice exhibited robust colonization of the spleen and liver compared to wildtype-infected mice (Fig 6A and 6B). Interestingly, ∆pcnB-infected mice formed two distinct populations: one population where the spleen and liver were colonized to the same levels as wildtype-infected mice, and a second population that had completely cleared the infection (Fig 6A and 6B). We isolated several ∆pcnB clones from the livers of colonized mice and found that their pYV stability and T3SS activity phenotypes were similar to the inoculum strain (S9 Fig). In addition, we sequenced the genomes of these isolates and could not identify any significant mutations, suggesting that host tissue colonization by the ∆pcnB mutant in a subset of mice does not stem from suppressor mutations that stabilize pYV. Taken together, these data suggest that PAP I increases the likelihood of Yersinia colonization of host tissues.

thumbnail
Fig 6. The pcnB gene is required for normal Y. pseudotuberculosis virulence in a mouse IP infection model.

Six- to eight-week-old C57Bl/6 mice were infected with 1-3x103 Y. pseudotuberculosis IP2666pIB1 via intraperitoneal (IP) injection. Tissues were collected, homogenized, and plated to determine CFU per gram (CFU/g) tissue 4 days post-inoculation. The log10 CFU/g tissue from the spleens (A) and livers (B) of infected mice are shown. Each circle represents one mouse organ; lines represent geometric means.

https://doi.org/10.1371/journal.ppat.1012655.g006

PAP I is required for maintenance of plasmid-encoded T3SS expression and antibiotic resistance in Shigella flexneri

The human pathogen Shigella flexneri harbors a virulence plasmid, pINV, with a RepFIIA origin similar to the one found on Yersinia pYV [1]. To test whether PAP I also regulates Shigella pINV, we deleted the pcnB gene in the S. flexneri M90T ∆ipaH2.5 (∆ipaH2.5::tetR) strain. We chose the ipaH2.5 deletion strain to introduce an antibiotic marker on the pINV virulence plasmid to force pINV retention if necessary. IpaH2.5 was the optimal target locus because IpaH2.5 and IpaH1.4 share 98% identity and are functionally redundant. Indeed IpaH2.5 is a pseudo gene in 2457T and is poorly expressed in M90T [76]. The resulting ∆ipaH2.5pcnB mutant was defective in Congo red binding compared to its parental strain (Fig 7A), suggesting a T3SS defect. Indeed, the ∆ipaH2.5pcnB strain exhibited a stark defect in expression and secretion of the T3SS translocon proteins IpaB, IpaC, and IpaD compared to the parental strain (Fig 7B and Fig 7C). Lastly, we introduced pTRC99 that confers IPTG-inducible expression of Yersinia PAP I into the ∆ipaH2.5 and ∆ipaH2.5pcnB strains. The Yersinia PAP I allele was able to partially complement the ShigellapcnB defect in T3SS expression (Fig 7B) and secretion (Fig 7C). Consistent with our previous data using Y. pseudotuberculosis strains (Fig 5C), deletion of pcnB led to a > 10-fold decrease in plating efficiency in the presence of antibiotic that could be complemented by PAP I expression (Fig 7D). Taken together, these data suggest that PAP I is essential for maintaining robust plasmid replication, resulting in increased expression of plasmid-encoded virulence and antibiotic resistance genes in pathogenic bacteria.

thumbnail
Fig 7. The pcnB gene is required for plasmid-encoded expression of T3SS and antibiotic resistance genes in Shigella flexneri.

(A) S. flexneri M90T ∆ipaH2.5 and ∆ipaH2.5pcnB, as well as a virulence plasmid cured (VP-) BS103 strain, were incubated on Congo red media at 37˚C. (B) S. flexneri M90T ∆ipaH2.5 and ∆ipaH2.5pcnB carrying pTRC99 with and without IPTG-inducible Yersinia PAP I were incubated at 37˚C, and secreted T3SS effector proteins were visualized after separation on as SDS-PAGE gel using anti-IpaB, anti-IpaC, and anti-IpaD antibodies. (C) S. flexneri M90T ∆ipaH2.5 and ∆ipaH2.5pcnB carrying pTRC99 with and without IPTG-inducible Yersinia PAP I were grown on either plain TCS media or TCS containing ampicillin and IPTG. Shown is one of two independent experiments.

https://doi.org/10.1371/journal.ppat.1012655.g007

Discussion

Y. pseudotuberculosis modulates the PCN of its pYV virulence plasmid to control the dosage of pYV-encoded genes in response to temperature [21,22]. This ability of Y. pseudotuberculosis to upregulate pYV PCN at mammalian body temperature is critical for its ability to cause disease. Here, we show that in addition to dynamic regulation of pYV PCN, Y. pseudotuberculosis requires the chromosomal gene pcnB, encoding the PAP I polyadenylase, to maintain pYV PCN homeostasis and prevent pYV loss from the bacterial population. The role of the pcnB gene in promoting virulence plasmid-encoded T3SS expression is conserved in both Y. pseudotuberculosis and S. flexneri. Although pcnB/PAP I has been shown to regulate plasmid replication of model plasmids in E. coli, this is the first study to link this gene to maintenance of native virulence plasmids in pathogenic bacteria. In addition, the requirement of Yersinia and Shigella pcnB/PAP I for robust plasmid-encoded antibiotic resistance suggests that PAP I represents a potential new drug target.

Putative PAP I orthologs have been bioinformatically identified in many bacterial species hailing from diverse phyla, and yet studies on pcnB/PAP I have historically been confined to a small number of non-pathogenic bacterial species [36]. E. coli PAP I (EcPAP) has been shown to promote RNA degradation of target transcripts. Degradation of RNA is generally initiated by the endonuclease RNase E and, in the absence of 3’ secondary structures, the RNA fragments produced by RNase E are then digested by the 3’-5’ exonucleases PNPase and RNase II [77]. However, RNase II- and PNPase-mediated RNA degradation is significantly impaired for transcripts that have terminal stem-loop structures, such as mRNAs containing intrinsic terminators at their 3’ ends and structured sRNAs [77]. PAP I has been shown to add poly(A) tails to the 3’ ends of transcripts containing terminal stem-loops structures to promote their decay [3739] and it is thought that PAP I-dependent polyadenylation of these transcripts provides a “toe-hold” for PNPase and RNase II to bind and digest the RNA [37,7880]. PNPase is known to be important for T3SS function in Y. pseudotuberculosis [8183] and PAP I has been shown to copurify with PNPase in E. coli [84]. Importantly, many of the major domains and catalytic residues are conserved between Yersinia and Shigella PAP I and EcPAP. EcPAP polyadenylase activity is abolished when the two catalytic residues Asp80 and Asp82 are mutated to alanine residues in E. coli [66,67]. To test if the phenotypes of the ∆pcnB strain was due to loss of PAP I polyadenylase activity, we mutated the corresponding catalytic residues (Asp114 and Asp116) in PAP I from Y. pseudotuberculosis to generate a PAPID2A strain with both catalytic residues replaced by alanine residues. The PAPID2A mutant recapitulated the phenotypes observed for the ∆pcnB strain, including reduced pYV PCN, plasmid stability, and T3SS activity. This supports the hypothesis that PAP I regulation of plasmid maintenance and T3SS activity in Y. pseudotuberculosis is dependent on its polyadenylase activity, and our data suggests that this may also be the case in S. flexneri.

EcPAP has been shown to polyadenylate both chromosomally- and plasmid-derived transcripts and was first identified due to its regulation of a sRNA that regulates plasmid replication [29,30]. EcPAP has been shown to regulate PCN for the IncFII family plasmid R1 by polyadenylating and targeting CopA regulatory sRNA for degradation, leading to de-repression of R1 plasmid replication and increasing R1 PCN [51]. This is consistent with our finding that PAP I is required for normal PCN and maintenance of the IncFII family Yersinia pYV plasmid, and for normal expression of the Shigella T3SS encoded on the related pINV virulence plasmid [1]. Taken together, these data point to the possibility that PAP I targets CopA sRNA from the Yersinia pYV and Shigella pINV cop-rep loci for polyadenylation. Bacteria are thought to maintain large extrachromosomal elements such as IncF virulence plasmids within a tight PCN range near a specific “set point” that is optimal for that species lifestyle [25]. This is particularly complicated in the case of pYV since this plasmid seems to have a different optimal PCN “set point” depending on temperature. Given that the ∆pcnB mutant displays a PCN defect at both 26°C and 37°C, this suggests that pYV plasmid replication rates are unusually low in the absence of PAP I in general, possibly due to the buildup of CopA sRNA. Reduced plasmid replication rates can also lead to plasmid stability defects when the plasmid replication rate drops low enough that cells can no longer reliably pass a copy of the plasmid to daughter cells during cell division [85]. Both reduced PCN and reduced plasmid stability can theoretically drive compounding disturbances in plasmid maintenance systems due to reduced gene dosage of stability systems such as partitioning and toxin-antitoxin (TA) systems. In keeping with this idea, our RNA-seq analysis supports the notion that the decrease in pYV-encoded gene dosage in the absence of PAP I leads to decreased expression of the ParDE TA system in ∆pcnB cells that may be responsible for killing plasmidless cells (S1 Data) [23]. Altogether, this supports the claim that PAP I is required for maintenance of the pYV PCN “set point” at both 26°C and 37°C, possibly through modulation of CopA sRNA levels. This, in turn, may decrease the frequency at which plasmidless daughter cells arise. Alternatively, PAP I may also regulate stability of additional transcripts that control plasmid partitioning and/or post-segregational killing. Future studies will focus on identification of polyadenylated transcripts in Yersinia and Shigella.

While there is an overall reduction in pYV PCN in the absence of pcnB/PAP I, ∆pcnB cells that retain the pYV plasmid still increase pYV PCN upon shifting from 26°C to 37°C. In addition, we have found that the pcnB gene is transcribed at 26°C and 37°C (S1 Data) and the PAP I protein is also produced at both temperatures (Fig 4A). Taken together, this suggests that PAP I is not required for the temperature-dependent shift in pYV PCN but rather for the maintenance of the pYV plasmid in general as it undergoes dynamic shifts in PCN during the Yersinia facultative lifestyle. We hypothesize that PAP I polyadenylates and promotes degradation of pYV-encoded CopA sRNA to regulate cellular CopA levels at both 26°C and 37°C. This would help maintain CopA levels within a range that promotes maintenance of pYV PCN near its optimal “set point” and ensuring that pYV-encoded gene dosage remains high enough to support replication and maintenance of the plasmid under conditions where pYV PCN is normally kept low. In the absence of PAP I, we hypothesize that pYV plasmid replication rates decrease due to abnormally high CopA sRNA levels, leading to reduced pYV PCN, plasmid stability, T3SS activity, and host tissue colonization.

We found that PAP I is required for normal Y. pseudotuberculosis virulence in a mouse intraperitoneal infection model, consistent with its role in promoting high pYV-encoded gene dosage and pYV stability, and therefore T3SS activity. Interestingly, ∆pcnB-infected mice fell into two groups: one in which the spleen and liver were colonized with Yersinia to wildtype-infected levels, and another in which no ∆pcnB cells could be recovered from spleens and livers four days post-inoculation. Overall, this led to a significant decrease in spleen and liver colonization by ∆pcnB compared to wildtype Y. pseudotuberculosis. Consistent with our finding that deletion of pcnB leads to enhanced pYV loss from the bacterial population in vitro, wildtype cultures used for mouse inoculation had 100% retention of pYV whereas the ∆pcnB inoculum had an average retention of 81% at the time of inoculation. This 19% decrease in pYV + ∆pcnB cells in the inoculum is not likely to explain the difference in virulence, as wildtype inoculums of 103 to 3x103 yielded similar spleen and liver colonization levels. These data suggest that pcnB/PAP I may aid Yersinia in surviving a colonization bottleneck during infection, highlighting the importance of understanding how PAP I and virulence plasmid gene dosage contribute to bacterial pathogenesis. All ∆pcnB cells recovered from the spleens and livers of infected mice retained at least one copy of the pYV plasmid despite the plasmid stability defect observed for this strain in vitro. These data suggest a selective pressure to retain pYV during growth in mouse tissues, consistent with the importance of the T3SS to Yersinia virulence. This contrasts with what we observe in vitro, when pYV and T3SS expression is a metabolic burden and not a benefit. These data suggest that pcnB/PAP I is required for maintenance of the pYV plasmid when pYV is dispensable to survival. This is necessary to ensure that enough of the Y. pseudotuberculosis population is pYV+ to enable colonization of a new host and survival in host tissues.

In addition to pYV and pINV, we found that pcnB is important for robust replication of sRNA-regulated plasmids encoding antimicrobial resistance (AMR) genes in Yersinia and Shigella. When Y. pseudotuberculosis or S. flexneripcnB cells are grown in the presence of the plasmid-selective antibiotic, we observed a ten-fold decrease in plating efficiency (Figs 5 and 7), consistent with previous studies in E. coli [29]. Similarly, we found a ten-fold decrease in GFP fluorescence in the Y. pseudotuberculosispcnB strain carrying the ColE1 pGFPuv plasmid compared to wildtype, suggesting a ten-fold decrease in plasmid-encoded gene expression in the absence of pcnB. In addition, time course experiments found that the majority of the ∆pcnB population loses the pGFPuv plasmid within just 10 hours of removing the selective antibiotic. These data support that ColE1 PCN and plasmid stability are reduced in the absence of PAP I, rendering the bacterial population more antibiotic susceptible. Interestingly, the rate at which pYV is lost from Y. pseudotuberculosis in vitro under non-T3SS inducing conditions was far slower than for pGFPuv. We passaged wildtype and ∆pcnB strains in LB medium at 26°C and while 100% of wildtype retained pYV, only ~60% of ∆pcnB cells retained pYV by 13 days with a still increasing rate of loss. As pGFPuv has no active plasmid partitioning or maintenance systems but pYV has both ParABS and ParDE systems, we hypothesize that the rate of plasmid loss in cells lacking PAP I activity will depend on the presence and type of plasmid-encoded mechanisms that promote plasmid stability. In addition, our data suggest that PAP I may only regulate plasmids whose replication rate is controlled by sRNA. Importantly, many plasmid families commonly found in bacteria from human and animal sources, such as IncF, IncB/O, IncA/C, IncL/M, and IncN, are known or predicted to be regulated by plasmid-encoded sRNA and therefore would be predicted to be influenced by PAP I activity [1,71,86].

Through our RNA-seq analysis we identified several differentially regulated transcripts in the Y. pseudotuberculosis ∆pcnB mutant that are involved in responding to several types of stress, including the universal stress protein UspB, the Yersinia urease operon, and several cold-shock proteins (S1 Data). Importantly, these differentially regulated genes are encoded on the Y. pseudotuberculosis chromosome and so should not be significantly affected by the pYV PCN defect in the ∆pcnB mutant. In addition, EcPAP from E. coli has been previously reported to play a critical role in regulating mRNA transcripts important for responding to stress where loss of PAP I leads to stabilization of stress response transcripts [47]. Deletion of pcnB in E. coli results in increased tolerance to several stresses, including osmotic stress, acid stress, heat shock, and cold shock [87]. Interestingly, we found that loss of PAP I does not affect Y. pseudotuberculosis viability following heat shock, growth at 4˚C, acid shock, or osmotic shock (S10 Fig). Our RNA-seq analysis also found that some stress response genes such as cspE are downregulated in ∆pcnB cells, suggesting that PAP I normally promotes stability of at least some stress-related transcripts in Y. pseudotuberculosis. These data suggest that while PAP I stabilizes sRNA-regulated plasmids in multiple bacterial species, its effect on stress responses is species-specific.

While E. coli EcPAP and PAP I from Y. pseudotuberculosis and S. flexneri are highly conserved in general, some regions of the proteins are less conserved and might account for their different impacts on stress tolerance. Interestingly, while the PAP I N-terminal region following the initial propeptide sequence is predicted to be disordered, this is also the region that displays the least amount of conservation between the three proteins (S2A Fig). In contrast, this N-terminal region is 100% conserved between Y. pseudotuberculosis and Y. pestis (S11 Fig). This disordered region is also significantly expanded in length for PAP I from Y. pseudotuberculosis and Y. pestis compared to E. coli and Shigella PAP I (S2A Fig). Given that disordered regions of RNA-binding proteins have been proposed to mediate interactions with target RNAs and/or other proteins [88], it is possible that Yersinia PAP I has evolved to target different RNA transcripts and/or interacts with one or more unique protein partners compared to EcPAP. Yersinia PAP I complements the plasmid-encoded antibiotic resistance defect of the ShigellapcnB mutant, suggesting that PAP I plays a conserved role in regulating plasmid-derived sRNAs. However, given the different role of PAP I in stress resistance in Yersinia and E. coli, PAP I may be adapted to regulate chromosomally-derived mRNA transcripts in a more species-specific way.

In this study, we show for the first time that pcnB/PAP I is required for maintenance of a large IncFII virulence plasmid (pYV) in Y. pseudotuberculosis and contributes to efficient colonization of host tissues. PAP I is required for maintenance of plasmids from multiple families in Y. pseudotuberculosis and S. flexneri (Figs 5, 7 and S8), including families that commonly include virulence and antimicrobial resistance plasmids. PAP I homologs can be found in many species of Gram-negative pathogenic bacteria, many of which harbor extrachromosomal plasmids important for their pathogenic lifestyles, and genomic studies show that the pcnB gene is highly subject to horizontal gene transfer [36]. Our data support the idea that bacterial PAP I has a conserved role in promoting the stability of many sRNA-regulated plasmids and may be critical for the establishment of new plasmids in a bacterial population following horizontal transfer by promoting plasmid replication. However, given the different effects of PAP I loss to stress resistance in E. coli and Yersinia, PAP I-mediated polyadenylation of transcripts that are chromosomally-encoded likely varies across species. Future studies will explore the possibility of targeting PAP I activity as a novel antibiotic and/or plasmid-curing strategy as well as the contribution of PAPI-mediated polyadenylation to regulation of gene expression in different pathogenic bacteria.

Materials and methods

Ethics statement

All experiments were approved by the University of California Santa Cruz Institutional Animal Care and Use Committee and were performed in accordance with National Institutes of Health guidelines.

Bacterial strains, plasmids, and growth conditions

All strains used in this study are listed in S2 Table. Y. pseudotuberculosis strains were grown in LB or 2xYT media (pH = 7) at 26°C or 37°C shaking at 250 rpm on a New Brunswick Scientific Innova 2300 platform shaker, unless otherwise indicated. S. flexneri were grown in tryptic soy broth media at 30°C or 37°C on a roller.

Construction of Y. pseudotuberculosis and S. flexneri mutant strains

All primers and plasmids used to generate Y. pseudotuberculosis strains for this study are listed in S3 and S4 Tables, respectively. Inserts were amplified by PCR using primers designed for Gibson Assembly and final recombinant plasmids were all made using the pCVD442 suicide vector backbone (λpir-dependent replicon, carbenicillin resistant [CarbR], sacB gene conferring sucrose sensitivity) (Addgene) following digestion with NdeI and BbsI. All ligations were performed using NEBuilder HiFi DNA Assembly kit (New England Biolabs). Recombinant pCVD442 plasmids were transformed into E. coli S17-1 λpir competent cells and introduced into Y. pseudotuberculosis IP2666pIB1 or YPIII/pIBX via conjugation. CarbR and irgansan-resistant (Yersinia selective antibiotic) clones were grown in the absence of antibiotics and plated onto media containing 10% sucrose to induce SacB-mediate toxicity for pCVD442 loss. Carb sensitive, sucrose-resistant, and Congo red-positive (pYV+) clones were screened by PCR and sequence verified by Sangar sequencing. pil insertion strains: A pil::Tn Y. pseudotuberculosis IP2666pIB1 ∆yop6 strain was originally isolated from a TnHimar1 library screened for altered NFκB induction compared to the parental strain [61]. The Tn insertion was then transferred to the wildtype IP2666pIB1 strain using the pSR47s suicide plasmid, as described above. The pil::pNQ Y. pseudotuberculosis YPIII/pIBX mutant was generated using the synthesized pNQ705 suicide plasmid carrying a truncated fragment of pil (Genescript) [89]. ∆pcnB: ~ 500 bp upstream of pcnB and ~500 bp downstream of pcnB was PCR amplified using genomic DNA (gDNA) from Y. pseudotuberculosis IP2666pIB1. Amplified fragments were cloned into pCVD442 to produce pCVD442::∆pcnB. ParB-GFP: To make ParB-GFP YPIII/pIBX strains, three fragments were amplified for insertion into pCVD442: (1) the last ~500 bp of the parB gene excluding the stop codon was amplified from Y. pseudotuberculosis gDNA, (2) msfGFP was amplified from pDK13 and (3) 500 bp downstream of the parB gene was amplified from Y. pseudotuberculosis gDNA. The resulting fragments were cloned into pCVD442 to generate a parB-msfGFP construct that includes 500 bp of downstream homology after msfGFP. PAPI-C-6xHis and PAPI-C-3xFLAG: To make PAPI-6xHis strains, pcnB was amplified from Y. pseudotuberculosis gDNA and cloned into pET28 that was previously digested with Xhol and NcoI to produce PAPI-C-6xHis. PAPI-C-6xHis was then amplified from pET28 and 500 bp downstream of pcnB was amplified from gDNA for insertion into pCVD442 to make pCVD442::PAPI-c-6xHis containing 500 bp of homology flanking the 6xHis tag. We subsequently found that the 6xHis tag was not sufficient to visualize the PAPI protein, and so alternative PAPI-C-3xFLAG strains were made in order to carry out western blot analyses. To make PAPI-3xFLAG, three fragments were amplified for insertion into pCVD442: (1) the pcnB gene was amplified from Y. pseudotuberculosis gDNA (2) 3xFLAG was amplified from pET28 and (3) 300 bp downstream of pcnB was amplified from Y. pseudotuberculosis gDNA. The fragments were then cloned into pCVD442 to make pCVD442::PAPI-c-3xFLAG containing 300 bp of downstream homology following the 3xFLAG tag. PAP 1 point mutations: To make PAP ID2A, PAP IL291R, and PAP IL291A mutants, we used the Q5 site-directed mutagenesis kit (New England Biolabs) to introduce base pair changes at the corresponding residues using the pCVD442::PAPI-c-6xHis or pCVD442::PAPI-c-3xFLAG recombinant plasmids as templates. ∆ipaH2.5pcnB Shigella: A fragment containing 200 bp of homology upstream and 240 bp of downstream pcnB flanking sequence was amplified from ECK0142 (∆pcnB E. coli K-12 BW25113) using pcnb_F and pcnb_R [90]. This fragment was introduced into the chromosome of ∆ipaH2.5::tetR Shigella using lambda red recombination [91,92]. The insertion was confirmed using pcnB_R_op and k2_wanner.

In vitro suppressor screen

LB cultures of the pil::pNQ YPIII/pIBX mutant strain were grown at 26ºC shaking overnight before diluting in fresh media and spotting for single colonies onto low calcium plates (LB supplemented with 20 mM sodium oxalate and 20 mM MgCl2). Plates were incubated at 37ºC for ~16 hrs to induce T3SS expression and selective pressure for growth of suppressor mutants. Clones that broke growth arrest and thus formed large colonies were selected and screened for changes in pYV PCN using the luciferase assay (see below). Suppressor mutants were also screened for changes in T3SS activity using an in vitro secretion assay (see below).

Identification of mutations arising from pil::pNQ suppressor screen

A subset of pil::pNQ YPIII/pIBX suppressor mutants were selected for whole genome sequencing. In brief, cells were grown shaking at in 2 mL LB at 26°C overnight and total genomic DNA was extracted using the Blood & Tissue DNeasy kit (Qiagen) according to manufacturer recommendations. Qubit quantification, library preparation, and Illumina paired-end sequencing with 150 bp read length was carried out by the UC Davis DNA Technologies Core. Adapters and low-quality reads were trimmed by Trimmomatic (Version 0.39) [93]. The trimmed sequences from each sample were aligned to the reference genome using BWA [94] The reference sequence was composed of the YPIII chromosome (CP009792.1) [95] and its plasmid (CP032567.1) [96]. Samtools [97] was used to sort and index the aligned reads. Duplicate reads originated from a single DNA fragment during sample preparation were located and tagged by MarkDuplicates in Picard (http://broadinstitute.github.io/picard/). Single nucleotide polymorphisms were detected and joined by GATK (Version 4.1.6) [98].

Droplet digital PCR (ddPCR)

ddPCR to determine pYV plasmid copy number was carried out as previously described [99]. Total DNA was extracted from bacterial cells using GeneJet Genomic DNA Purification kit (Thermo Scientific) according to the manufacturer’s recommendations for Gram-negative bacteria. Each genomic DNA sample was split into two reactions and the primer pair F_chrom_ddPCR/R_chrom_ddPCR was used to amplify chromosomal DNA and F_pYV_ddPCR/R_pYV_ddPCR was used to amplify pYV DNA. Individual ddPCR samples were prepared as follows: 10.5 µL of total genomic DNA was combined with 12.5 µL of 2xEVA-Green master mix for unlabeled probes (Bio-Rad), 1 µL of HindIII-HF (NEB), and 1 µL of respective primer pairs (200 nM final concentration) in 8-strip PCR tubes. PCR tubes were incubated at room temperature for 10 mins to allow HindIII to digest genomic DNA. Droplet generation was carried out using an Automated Droplet Generator (Bio-Rad) and droplets were subsequently transferred to a deep-dish qPCR plate (Bio-Rad) for PCR amplification. PCR was carried out with hot-start activation at 95°C for 5 mins following by denaturation at 94°C for 30s, amplification at 58°C for 1 min over 40 cycles, and signal stabilization at 4°C for 10 mins and 90°C for 5 mins. A ramp rate of 2C/s was used for all PCR steps. Droplets were analyzed using a QX200 droplet reader (Bio-Rad) and data was analyzed using QuantaSoft Analysis Standard Edition (version 1.2) (Bio-Rad). Statistical significance was calculated using a one-way ANOVA with Tukey’s multiple-comparisons test (**** P < 0.0001, *** P < 0.001, ** P < 0.01, * P < 0.05). All graphs and statistical analyses were generated using GraphPad Prism (10.2.0).

Luciferase pYV plasmid copy number assay

Overnight cultures for strains in the YPIII/pIBX background were grown shaking at 26°C before subculturing to an OD600 of 0.2 in 2xYT low calcium media (containing 20mM sodium oxalate and 20mM MgCl2). Cultures were then grown shaking for 1.5 hrs at 26°C before shifting to 37°C. Luminescence and OD600 were measured after 1.5 hrs at 26°C just before shifting to 37°C and every hour after shifting to 37°C. Samples were collected at each timepoint in white walled, clear bottom 96 well plates and luminescence (using lum aperture for 96 well plate with measurement time = 0.1s) and OD600 (using Photometric 600 excitation filter) was measured using a PerkinElmer Multimode Plate Reader EnVision system. Relative plasmid copy number was determined by dividing luminescence by OD600 for the same sample. Statistical analysis was determined using a one-way ANOVA with Dunnett’s multiple comparisons test (**** P < 0.0001, *** P < 0.001, ** P < 0.01, * P < 0.05) where applicable. All graphs were made using GraphPad Prism (10.2.0).

ParB-msfGFP microscopy and image analysis

Wildtype and ∆pcnB YPIII/pIBX cells expressing ParB-msfGFP from LB plates supplemented with kanamycin were inoculated into EZ Rich Defined Medium (EZRDM) (Teknova) without antibiotic supplementation. EZRDM medium was chosen to reduce medium autofluorescence for downstream imaging purposes. Cultures were grown shaking at 200 rpm overnight at 26°C in a New Brunswick Scientific Excella E24 shaker to a final OD600 of ~2–4. A secretion analysis was performed to confirm that Y. pseudotuberculosis displays normal T3SS activity when grown in EZRDM under T3SS-inducing conditions (37°C, supplemented with 20 mM sodium oxalate and 20 mM MgCl2), referred to as low calcium EZRDM (S12 Fig). In addition, following incubation at 26˚C or under 37°C/low calcium conditions as in Table 1, 99% and 97% of ParB-msfGFP clones retained pYV, respectively, indicating that the ParB-msfGFP construct does not disturb plasmid partitioning. For non-T3SS inducing conditions, overnight cultures were diluted to an OD600 of ~0.2 in fresh EZRDM and grown shaking in a New Brunswick Innova 44 incubator shaker for 3hrs at 26°C. For T3SS-inducing conditions, overnight cultures were diluted to an OD600 of ~0.2 in low calcium EZRDM and grown shaking in a New Brunswick Innova 44 incubator shaker for 1.5 hrs at 26°C before shifting to 37°C for an additional 1.5 hrs. Cells were prepared for imaging by spotting onto a 1% agarose-low calcium EZRDM pad and covering with a no. 1.5 coverslip. Imaging was carried out using a Nikon Eclipse Ti microscope equipped with a 100X Plan Apo 1.45 NA phase-contrast oil objective, a Hamamatsu Orca-Flash4.0 V2 CMOS camera, and CoolLED pE-400 (Lumencor). The microscopes were controlled by the Nikon Elements software. The following Chroma filter cubes were used to acquire the fluorescence images: GFP: excitation ET470/40x, dichroic T495lpxr, emission ET525/50 m. Images were acquired with 50 ms of exposure (50% power) for GFP and 100 ms for phase contrast. For each strain and condition, three independent biological replicates (inoculated with different colonies) were grown and imaged.

For image analysis, cells were segmented and cell outlines were generated using the open-source Oufti software [100] using the following parameters: Edgemode, 1; Dilate, 1; openNum, 0; InvertImage, 0; ThreshFactorM, 0.86254; ThreshMinLevel, 0.3; EdgeSigmaL, 0.5; LogThresh, 0. Cell meshes were further curated using the SVMCuratedCellDetection.m script to identify and remove misdetected cells [101]. To quantify the number of pYV copies per cell, detection of pYV spots was performed using the ImageJ plug-in package ThunderSTORM [102,103]. For cells grown at 26°C, image filtering used a wavelet filter (B-spline) with a scale of 2.0 and order of 3.0. Under non-T3SS-inducing conditions, a local maximum using 5.0*std(Wave.F1) and a connectivity of 8-neighborhood was used to localize molecules based on peak intensity thresholds, and sub-pixel localization used a Gaussian point spread function (PSF) with a fitting radius of four pixels and an initial sigma of one pixel. For the 37°C/low calcium condition, the parameters were adjusted where the local maximum instead used 2.0*std (Wave.F1) and a connectivity of 8-neighborhood, and sub-pixel localization used a Gaussian PSF with a fitting radius of three pixels and an initial sigma of one pixel. Once parameter optimization was completed, the custom-made ImageJ macro BatchProcess_ThunderSTORM,ijm was used to iterate ThunderSTORM spot detection over all image files, applying the same parameters for a given biological replicate. Detected spots were linked with cell meshes using the custom MATLAB code analyze_ensemble_spot_intensity.m, as detailed further below. Code developed as part of this study has been deposited in the publicly accessible Github code repository (https://github.com/JacobsWagnerLab/published/tree/master/Schubert_et_al_2025). Three independent experiments were performed and analyzed per strain and condition.

Elaborating on the MATLAB script analyze_ensemble_spot_intensity.m, each cell was quantified by averaging whole cell intensity, recording the number of ThunderSTORM-detected spots, and noting the cell length. Only cells with length of at least 1 µm were kept to rule out incorrect cell segmentations. Each cell was identified and measured from its original Oufti mesh. There, the fluorescent GFP images were background-subtracted, then cell contours were used to obtain the boundaries of the cell area. Cellular fluorescence was determined by Oufti [100]. To link ThunderSTORM spots, (x,y) localizations, to Oufti meshes, the cell meshes were first converted to MATLAB polygons using the function polyshape. The function inpolygon was then used to feed the (x,y) localizations and polygon shape to find if any spots occurred inside the cell. For Fig 3 C-E, cells with zero spot were excluded from the analysis.

To assess the fraction of cells devoid of GFP signal, strains were grouped by condition (inducing vs. non-inducing as 37°C/low calcium vs. 26°C, respectively). Each strain in the condition was subsetted by random sampling without replacement to match the lowest N value (7,033 cells in 26°C and 10,003 cells in 37°C/low calcium) using the function datasample. These data were then bootstrapped 100 times to recalculate histograms and determine the error for each bin (using the custom function Hist_Errors). Since the ∆pcnB conditions had clear bimodal distributions for low/high fluorescent states, an Otsu threshold was calculated using the function otsuthresh to find the split between them [104]. Cell with intensity values below this threshold were deemed cells without plasmid content. The background spot detection of cells below the Otsu threshold were plotted in S5 Fig. To compare these two distribution shapes statistically, a Kolmogorov-Smirnov (KS) test was used via the function kstest2.

Images were visualized using NIS Elements and Fiji. Image pixel intensity values were autoscaled for display using Fiji, and all images were converted to RGB format for display. Data were plotted using GraphPad Prism 10.2.0, and Adobe Illustrator was used to generate figures involving images.

In vitro pYV plasmid stability assay

Cells were struck for single colonies onto LB plates and grown at 26°C for 1.5-2 days. To test plasmid stability after 26°C-only passage, single colonies were then patched onto LB plates for ~16 hrs at 26°C before heavily streaking for single colonies onto fresh LB plates at 26°C for 1.5-2 days. To test plasmid stability after exposure to T3SS-inducing conditions (37°C), the same colonies were also patched onto LB plates supplemented with 20 mM sodium oxalate to induce T3SS activity for ~16 hrs at 37°C before streaking for single colonies onto LB plates and returning to 26°C to grow for 1.5-2 days. Final plasmid stability was determined for both conditions by patching single colonies from the final 26°C streak on LB plates supplemented with 20 mM sodium oxalate and containing 1% Congo red. The percentage of cells that retained the pYV plasmid was calculated by dividing the number of red (pYV+) CFU by the total number of CFU. Single colony PCR was used on a subset of patches to validate that red CFU retain pYV and while white CFU do not.

In vitro T3SS activity assay

Quantification of secreted Yersinia T3SS cargo was carried out as previously described [105]. Y. pseudotuberculosis cultures were grown shaking overnight at 26°C before subculturing in LB low calcium media (LB containing 20 mM sodium oxalate and 20 mM MgCl2). Cultures were grown shaking at 26°C for 1.5 hrs before shifting to 37°C/shaking for an additional 1.5 hrs. Cultures were normalized to the same number of cells by normalizing OD600 values and pelleted at 13,200 rpm (~19,000 xg) for 15 mins at room temperature. Supernatants were transferred to new tubes and proteins precipitated with 10% trichloroacetic acid (TCA). A bovine serum albumin (BSA) protein control was spiked into each sample immediately before the addition of TCA. Samples were incubated in TCA on ice for at least 1 hr before pelleting at 13,200 rpm (19,000 xg) for 15 mins at 4°C. Pellets were then washed twice with ice-cold 100% acetone and resuspended in final sample buffer (FSB) containing 0.2M dithiothreitol (DTT). Samples were boiled for 10 mins at 95°C before loading and separating on a 12.5% SDS-PAGE gel. Gels were stained with Coomassie blue to visualize proteins and imaged using Bio-Rad Image Lab Software Quantity and Analysis tools.

Shigella T3S secretion assay

S. flexneri cultures were grown with shaking overnight in tryptic soy broth (TCS) media with 15 µg/mL tetracycline and 50 µg/mL kanamycin at 37°C. In the morning, the cultures were sub-cultured in TCS and grown for 2.5 hours with shaking at 37°C to reach OD600 ~ 1. Cultures were normalized to the same number of cells based on the OD600 and pelleted at 13,000 rpm (~16,000 xg) for 1 min before resuspending in PBS and 10 µM Congo red and incubated for 30 mins shaking at 37°C. Pellets and supernatants were separated by centrifugation and supernatants were transferred to new tubes and precipitated with 10% TCA. Supernatant samples were incubated on ice and subsequently pelleted at 15000 rpm (~21,000 xg) for 15 mins at 4°C. Pellets were then washed with ice-cold 100% ethanol and resuspended in 1x loading dye buffer with 5% β-mercaptoethanol. Samples were boiled for 10 mins at 95°C before loading on a 12% SDS-PAGE gel for western blot analysis.

RNA isolation and RNA-seq analysis

Y. pseudotuberculosis IP2666pIB1 strains were grown in 3 mL LB overnight at 26°C and diluted the following morning to an OD600 of 0.2 in 5 mL of fresh LB. Each strain was diluted into two separate cultures (one for each temperature). For 26°C samples, cultures were diluted in plain LB media and grown shaking at 26°C for 3 hrs before extracting RNA. For 37°C samples, cultures were diluted into LB low calcium media (containing 20 mM sodium oxalate and 20 mM MgCl2) and grown shaking at 26°C for 1.5 hours before shifting to 37°C to growing shaking for an additional 1.5 hours. After incubating, 1–2 mL of each culture was collected and pelleted for 5 mins at 4,000 rpm (~200 xg). Supernatants were removed and cell pellets were resuspended in 1mL RNA Protect (Qiagen) and total RNA was isolated using the RNeasy minikit (Qiagen) according to the manufacturer’s protocol. DNA was removed from samples using the TURBO DNA-free kit (Life Technologies/Thermo Fischer) and RNA quality was determined using an Agilent 2000 Bioanalyzer. Samples were DNase treated with Invitrogen DNase. Library preparation was performed using Illumina’s Stranded Total RNA Prep Ligation with Ribo-Zero Plus kit and 10 bp IDT for Illumina indices. Sequencing was done on a NovaSeq 6000 giving 2x51bp reads. Demultiplexing, quality control, and adapter trimming was performed with bcl-convert (v4.0.3). Read mapping was performed with HISAT2 [106]. Read quantification was performed using Subread’s featureCounts functionality [107]. Read counts were normalized using edgeR’s Trimmed Mean of M values (TMM) algorithm (S1 Data) [108]. Subsequent values were then converted to counts per million (cpm). Differential expression analysis was performed using edgeR’s exact test for differences between two groups of negative-binomial counts with an estimated dispersion value of 0.1. Genes for which the |logFC| > 1 and p < 0.05 were considered differentially expressed (S1 Data).

Heatmaps for pYV-encoded genes were generated using average TMM values via ClustVis [109]. RNA-Seq data are available for viewing, and the track hub data can be found at http://lowelab.ucsc.edu/hubs/yersinia_pcnB_pil_expression/hub.txt on the UCSC Microbial Genome Browser. For these data, chromosomal reads were normalized separately from pYV-encoded reads due to differences in pYV PCN among samples. For this analysis, raw paired reads were aligned to the Y. pseudotuberculosis IP2666pIB1 genome (ASM381434v1) using Bowtie2 (v.2.3.5.1) with default options. Bam files were further processed to remove PCR duplicates using samtools (v1.15.1) as follows, samtools sort -n {input_bam} | samtools fixmate -m - - | samtools sort - | samtools markdup -r - - | samtools view -bq 10 -f 0x1 -> {output_bam}. Finally, bamCoverage-deeptools (v3.5.4) was used to normalize the chromosomal read counts using the following options: --normalizeUsing CPM --ignoreForNormalization NZ_CP032567.1 --outFileFormat bedgraph --binSize 1 --region NZ_CP032566.1. For the non-normalized pYV reads we used bamCoverage-deeptools with options --ignoreForNormalization NZ_CP032566.1 --outFileFormat bedgraph --binSize 1 --region NZ_CP032567.1. Finally, the separate bedgraph files were concatenated and converted to bigwig format using bedGraphToBigWig (v4) with default options.

Western blot analysis

Cells were grown at the indicated temperature before preparing samples for western blotting. Samples were normalized to the same number of cells using OD600 at the time of sample collection. Bacterial pellets were then resuspended in FSB containing 0.2M DTT and boiled at 95°C for 15 mins. Secreted proteins were precipitated using TCA in the same way as described for the in vitro secretion assay above. The same volume of each sample was separated on a 12.5% SDS-PAGE gel and proteins were transferred to a blotting membrane (Immunobilon-P) using a wet mini trans-blot cell (Bio-Rad) at 4°C. Blots were blocked for 1 hr in Tris-buffered saline containing Tween 20 and 5% milk. Blots were probed with anti-RpoA (gift from Melanie Marketon), goat anti-YopE (Santa Cruz Biotech), mouse M2 anti-FLAG (Sigma), and horseradish peroxidase-conjugated secondary antibodies (Santa Cruz Biotech). Bands were visualized using a BioRad ChemiDoc and quantification analysis was performed using Image Lab software (Bio-Rad).

For S. flexneri strains, samples were separated by a 12% SDS-PAGE gel and transferred to a nitrocellulose membrane. Blots were probed with anti-IpaB, anti-IpaC, and anti-IpaD antibodies, and anti-rabbit secondary antibodies. Bands were visualized using SuperSignal West Pico PLUS Chemiluminescent Substrate on an Azure 300 Imager.

Mouse Infections

C57BL/6 mice were purchased from Jackson Laboratory. Mice were housed in specific-pathogen free conditions in microisolator cages, and provided with food and water ad libitum. Six- to eight-week-old C57Bl/6 mice were infected with 1-3x103 Y. pseudotuberculosis via intraperitoneal (IP) injection. LB overnight cultures of Y. pseudotuberculosis were grown shaking at 26°C before spinning down at 5000 rpm (~300 xg) and resuspending in sterile PBS (pH 7.4). CFU used for the inoculum cultures were confirmed to contain pYV prior to infection using single colony PCR with primers specific to the pYV plasmid. Samples were then diluted in PBS such that 100 µL contained 1-3x103 cells. Inoculums were plated to confirm the inoculation dose and to estimate the percentage of cells that were pYV+ by patching onto LB plates supplemented with 20 mM sodium oxalate and containing 1% Congo red dye. The plasmid retention of the starting inoculums was found to be 100% for wild type and 81% on average for ∆pcnB. Mice were injected with 100 µL of inoculum and spleens and livers harvested four days post-inoculation. Organs were homogenized and serial dilutions of the homogenate plated to determine CFU per gram (CFU/g) of tissue.

Construction of PAP I expression vector

The pcnB ORF was PCR amplified from Y. pseudotuberculosis genomic DNA using the primer pair FpcnB_pTrc/RpcnB_pTrc and ligated into pTrc99a previously digested with NcoI and Xbal using NEBuilder HiFi DNA Assembly kit (New England Biolabs, Inc.). Constructs were transformed into DH5α E. coli for propagation and sequence verified via Sangar sequencing. The resulting pTrc99a::PAPI recombinant expression vector was introduced to wildtype and ∆pcnB Y. pseudotuberculosis by electroporation and selection on LB plates containing carbenicillin. Expression of PAPI was induced by plating onto LB plates containing 0.2 mM IPTG.

Spot tests to analyze antibiotic resistance conferred by pGFPuv, pTrc99, and pNF06

Wildtype and ∆pcnB Y. pseudotuberculosis IP2666pIB1 were electroporated with 1 µL of pGFPuv [CarbR] (Gifted by Dr. Manel Camps), pTrc99a, or pNF06::ccdAB [KanR] (Gifted by Dr. Laurence Van Melderen) and single colonies were selected by plating on LB plates containing carbenicillin (pGFPuv, pTrc99a) or kanamycin (pNF06). For spot test dilution series analyses, overnight cultures were grown at 26°C in the presence of antibiotics before diluting in PBS (pH 7.4) and making a series of 1:10 dilutions. Serial dilutions were spotted onto LB plates containing no antibiotic or LB plates containing the selective antibiotic and plates were visualized after 1-1.5 days of growth at 26°C.

∆ipa2.5::tetR and ∆ipa2.5∆pcnB S. flexneri M90Twere electroporated with pTrc99a, and single colonies were selected by plating on LB plates containing ampicillin. For spot tests, overnight cultures were grown at 30°C in the presence of antibiotics before diluting in PBS (pH 7.4) and making a series of 1:10 dilutions. Serial dilutions were spotted onto LB plates containing no antibiotic or LB plates containing the selective antibiotic and plates were visualized after 1 day of growth at 30°C.

pGFPuv plasmid loss curve

Wildtype and ∆pcnB Y. pseudotuberculosis IP2666pIB1 lacking pYV (pYV-) were electroporated with pGFPuv as described above. Overnight cultures were grown at 26˚C in the presence of carbenicillin. Overnight cultures were diluted 1:1000 into LB media without antibiotics to allow loss of the plasmid. To assess plasmid retention at each timepoint, aliquots of the cultures were plated onto LB agar and incubated at 26˚C. Fifty single colonies from each sample were patched onto LB agar containing carbenicillin. Percentage of plasmid retention was calculated as the number of patched colonies able to grow in the presence of carbenicillin relative to the total number of patched colonies.

Supporting information

S1 Fig. A transposon insertion into pil leads to a constitutively high pYV PCN, elevated T3SS expression, and a severe growth defect under T3SS-inducing conditions.

(A) HEK293T cells expressing an NFκB luciferase reporter were left uninfected (uninf) or were infected with an effectorless ∆yop6 strain (∆yopHEMOJ), a ∆yscNU T3SS-deficient strain, or ∆yop6/pil::Tn in the Y. pseudotuberculosis IP2666pIB1 background. Averages of three independent replicates ± standard error the mean are shown (Student t-test, p < 0.04). (B) Schematic representation of the location of pil. The pil locus is located ~123 bp upstream of the copB gene. (C) Wildtype, pil::Tn, and ∆pil IP2666pIB1 were grown at 37°C/low calcium and secreted T3SS cargo proteins (Yops) were precipitated and visualized by Coomassie blue staining. Bovine serum albumin (BSA) serves as a protein precipitation control. Secreted YopE protein levels relative to the BSA control were quantified using densitometry. Graph shows averages ± standard error of the mean for three independent experiments. ns, not significant as determined by ANOVA with Tukey’s multiple comparisons test (p = 0.97). (D-E) Relative pYV PCN was estimated for strains in the YPIII/pIBX background of Y. pseudotuberculosis using a luciferase plasmid copy number assay. For each timepoint, luminescence was measured and normalized to cell density (OD600). Averages ± standard error of the mean for three independent experiments are shown. Statistical significance was calculated using a one-way ANOVA with Bonferroni post-test (**** p < 0.0001, *** p < 0.001, **p < 0.01, * p < 0.05). (F) Serial dilutions for wildtype YPIII/pIBX and the pil::pNQ congenic Y. pseudotuberculosis strains were spotted onto low calcium agar plates for ~16 hours at 37°C before imaging. The yellow arrow indicates an example of a large colony in the pil::pNQ mutant background that represents a candidate suppressor mutant.

https://doi.org/10.1371/journal.ppat.1012655.s001

(PDF)

S2 Fig. PAP I is highly conserved among E. coli, Y. pseudotuberculosis, and S. flexneri.

(A) PAP I protein sequences from E. coli K12, Y. pseudotuberculosis IP2666, and S. flexneri M90T strains were aligned using Clustal Omega. The PAP I head domain (blue), neck domain (green), body domain (purple), and leg domains (yellow) are shown [67]. Residues in boxes represent known catalytic residues from EcPAP and the residue indicated with an arrow represents the residue that was mutated in the L291R pcnB suppressor mutants. (B) Predicted structures of EcPAP and Y. pseudotuberculosis PAP I obtained using AlphaFold Protein Structure Database. The homologous domains were color-coded with AlphaFold Structure Tools, and follow the coloring scheme described in panel A. (C) Residues D114, D116, and L291 are highlighted in red and indicated by red arrows. The N-terminus (upstream of the head domain) is indicated in black. The unstructured C-termini are not shown in the structure predictions.

https://doi.org/10.1371/journal.ppat.1012655.s002

(PDF)

S3 Fig. T3SS gene mRNA levels are higher in the pil::Tn mutant and lower in the ∆pcnB mutant compared to wildtype.

Heat maps displaying relative expression of pYV-encoded genes from RNA-seq analysis of Y. pseudotuberculosis IP2666pIB1 strains grown at 26°C or 37°C/low calcium.

https://doi.org/10.1371/journal.ppat.1012655.s003

(PDF)

S4 Fig. The pil::Tn strain exhibits normal temperature and calcium regulation of T3SS activity.

Strains were grown in regular LB or low calcium LB media, at either 26°C or at 37°C. Secreted proteins in the supernatant were precipitated and visualized by SDS-PAGE and Coomassie blue staining. Bovine serum albumin (BSA) was added as a protein precipitation control. Data shown is representative data of three biological replicates.

https://doi.org/10.1371/journal.ppat.1012655.s004

(PDF)

S5 Fig. Transposon insertion in the pil locus alters RNA-Seq read patterns at the cop-rep locus.

Reads from RNA-seq analysis mapped to the cop-rep locus and adjacent pil locus from wildtype and pil::Tn (pil) Y. pseudotuberculosis IP2666pIB1 grown at 26°C or 37°C/low calcium. The putative pil locus is indicated by a black box and the approximate location of the Tn insertion is indicated with an arrow.

https://doi.org/10.1371/journal.ppat.1012655.s005

(PDF)

S6 Fig. The majority of Yersinia cells with low ParB-msfGFP fluorescence have no detectable pYV spots.

(A) Distribution of detected fluorescent ParB-msfGFP spots in the parental or ∆pcnB cells in low-fluorescence state in Fig 3B (26ºC, left). The fraction occupancy of each bin is annotated above each bar. The total number of cells in the low-fluorescence state is noted in each graph. The number of cells in each bin was normalized to the total number of cells for the frequency. (B) Same as (A) but for the cells in low-fluorescence state under 37ºC/low calcium condition.

https://doi.org/10.1371/journal.ppat.1012655.s006

(PDF)

S7 Fig. The L291R mutation disrupts PAP I steady-state levels at 37˚C. Y. pseudotuberculosis IP2666pIB1 strains harboring various PAP IFLAG alleles grown at 26°C or 37°C/low calcium were pelleted and prepared for western blot analyses using anti-FLAG and anti-RpoA (for a loading control) antibodies.

Averages ± standard error of the mean are shown from two independent replicates for the D2A mutant and three independent replicates for the remaining strains. Fig 4A shows one of the replicates. Statistical significance was calculated using a one-way ANOVA with Dunnett’s multiple comparisons test (**** p < 0.0001, *** p = 0.0002, * p < 0.02).

https://doi.org/10.1371/journal.ppat.1012655.s007

(PDF)

S8 Fig. The pcnB gene is required for plasmid-mediated antibiotic resistance in Y. pseudotuberculosis

Wildtype and ∆pcnB Y. pseudotuberculosis IP2666pIB1 harboring either pBAD33 or pACYC184 were grown overnight in LB supplemented with 20 µg/mL chloramphenicol, and the overnight cultures spotted onto LB agar lacking or containing chloramphenicol to assess plasmid retention. Plates were incubated at 26°C for ~16 hours before imaging. Each experiment was carried out for a total of two independent experiments.

https://doi.org/10.1371/journal.ppat.1012655.s008

(PDF)

S9 Fig. Y. pseudotuberculosis isolated from infected livers demonstrate similar plasmid loss and T3SS activity phenotypes as their parental strains.

Independent colony forming units from infected mouse livers were isolated and assessed for their ability to retain pYV and carry out T3SS activity. WT-3 and WT-5 are wildtype IP2666pIB1-derived isolates from two different mice. ∆pcnB-2–9, ∆pcnB-2–10, ∆pcnB-3–1, and ∆pcnB-3–2 are ∆pcnB-derived isolates from two different mice. (A) Liver isolates and their parental strains were incubated overnight at 26˚C in LB or 37˚C in LB/low calcium media. Colonies were patched onto low calcium media containing Congo red to induce T3SS activity and assess the percentage of colonies that retained pYV (i.e.,-red colonies). (B) Liver isolates and their parental strains were incubated in LB low calcium media at 37˚C, and secreted proteins visualized by Coomassie blue staining. Bovine serum albumin (BSA) was added as a protein precipitation control. Data shown is representative of two independent experiments.

https://doi.org/10.1371/journal.ppat.1012655.s009

(PDF)

S10 Fig. Loss of PAP I does not affect Y. pseudotuberculosis growth following stress exposure.

(A) Wildtype and ∆pcnB Y. pseudotuberculosis IP2666pIB1 cultures were grown to mid-log phase at 26°C before shifting to 42°C for 1 hour to induce heat shock. Spot dilutions were plated onto LB plates and incubated at 26°C for ~16 hours before imaging. (B) Strains in the IP2666pIB1 background were grown at 26°C overnight (stationary phase) before diluting and spotting into LB plates. Plates were incubated at 26°C for 4 hours before transferring to 4°C and allowing growth for ~2 days prior to imaging. (C) Wildtype and ∆pcnB Y. pseudotuberculosis IP2666pIB1 were grown at 37°C (low calcium) to mid-log phase before inducing stress. Growth was assayed by plating spot dilutions following stress exposure. Stress was induced by adjusting media to pH = 3.0 to induce acid shock or by addition of 800 mM NaCl2 to induce osmotic shock.

https://doi.org/10.1371/journal.ppat.1012655.s010

(PDF)

S11 Fig. PAP I from Y. pseudotuberculosis and Y. pestis are 100% conserved.

PAP I sequences from Y. pseudotuberculosis IP2666pIB1 and Y. pestis KIM5.

https://doi.org/10.1371/journal.ppat.1012655.s011

(PDF)

S12 Fig. Y. pseudotuberculosis displays normal T3SS activity in EZ-RDM low calcium media.

Y. pseudotuberculosis IP2666pIB1 wildtype, ∆pcnB, and pYV- strains were grown in either low calcium LB or low calcium EZ-RDM media. The pYV- strain cured of pYV was used as a negative control [110]. Secreted proteins were visualized by Coomassie blue staining. Bovine serum albumin (BSA) was added as a protein precipitation control. Data shown is representative of two independent experiments.

https://doi.org/10.1371/journal.ppat.1012655.s012

(PDF)

S1 Table. Phenotypic categories and mutations identified in the suppressor screen.

https://doi.org/10.1371/journal.ppat.1012655.s013

(DOCX)

S2 Table. Y. pseudotuberculosis strains used in this study.

https://doi.org/10.1371/journal.ppat.1012655.s014

(DOCX)

S1 Data. Dataset. Transcriptome analysis of Y. pseudotuberculosis IP2666pIB1 wildtype, pil::Tn, ∆pcnB, and pil::Tn/∆pcnB congenic strains.

https://doi.org/10.1371/journal.ppat.1012655.s017

(XLSM)

Acknowledgments

We would like to acknowledge Dr. Manel Camps (UC Santa Cruz) for providing the pGFPuv plasmid as well as general advice and guidance on this work. We would also like to acknowledge Dr. Laurence Van Melderen (Université Libre de Bruxelles) for providing us with the pNF06::empty and pNF06::ccdAB constructs. Finally, we would like to thank Dr. Petra Dersch (Universität Münster) for providing general advice and technical support for this project.

References

  1. 1. Pilla G, Tang CM. Going around in circles: virulence plasmids in enteric pathogens. Nat Rev Microbiol. 2018;16(8):484–95. pmid:29855597
  2. 2. Gemski P, Lazere JR, Casey T, Wohlhieter JA. Presence of a virulence-associated plasmid in Yersinia pseudotuberculosis. Infect Immun. 1980;28(3):1044–7. pmid:6249747
  3. 3. Cornelis GR. The Yersinia Yop virulon, a bacterial system to subvert cells of the primary host defense. Folia Microbiol (Praha). 1998;43(3):253–61. pmid:9717252
  4. 4. Sun Y-C, Jarrett CO, Bosio CF, Hinnebusch BJ. Retracing the evolutionary path that led to flea-borne transmission of Yersinia pestis. Cell Host Microbe. 2014;15(5):578–86. pmid:24832452
  5. 5. Glatter KA, Finkelman P. History of the Plague: An Ancient Pandemic for the Age of COVID-19. Am J Med. 2021;134(2):176–81. pmid:32979306
  6. 6. Cornelis GR, Boland A, Boyd AP, Geuijen C, Iriarte M, Neyt C, et al. The virulence plasmid of Yersinia, an antihost genome. Microbiol Mol Biol Rev. 1998;62(4):1315–52. pmid:9841674
  7. 7. Portnoy DA, Wolf-Watz H, Bolin I, Beeder AB, Falkow S. Characterization of common virulence plasmids in Yersinia species and their role in the expression of outer membrane proteins. Infect Immun. 1984;43(1):108–14. pmid:6317562
  8. 8. Demeure C, Dussurget O, Fiol GM, Le Guern A-S, Savin C, Pizarro-Cerdá J. Yersinia pestis and plague: an updated view on evolution, virulence determinants, immune subversion, vaccination and diagnostics. Microbes Infect. 2019;21(5–6):202–12. pmid:31252217
  9. 9. Cornelis GR. The type III secretion injectisome. Nat Rev Microbiol. 2006;4(11):811–25. pmid:17041629
  10. 10. Coburn B, Sekirov I, Finlay BB. Type III secretion systems and disease. Clin Microbiol Rev. 2007;20(4):535–49. pmid:17934073
  11. 11. Bliska JB, Wang X, Viboud GI, Brodsky IE. Modulation of innate immune responses by Yersinia type III secretion system translocators and effectors. Cell Microbiol. 2013;15(10):1622–31. pmid:23834311
  12. 12. Deng W, Marshall NC, Rowland JL, McCoy JM, Worrall LJ, Santos AS, et al. Assembly, structure, function and regulation of type III secretion systems. Nat Rev Microbiol. 2017;15(6):323–37. pmid:28392566
  13. 13. Schubert KA, Xu Y, Shao F, Auerbuch V. The Yersinia Type III Secretion System as a Tool for Studying Cytosolic Innate Immune Surveillance. Annu Rev Microbiol. 2020;74:221–45. pmid:32660389
  14. 14. Brubaker RR. The Vwa+ virulence factor of yersiniae: the molecular basis of the attendant nutritional requirement for Ca++. Rev Infect Dis. 1983;5 Suppl 4:S748-58. pmid:6195719
  15. 15. Sturm A, Heinemann M, Arnoldini M, Benecke A, Ackermann M, Benz M, et al. The cost of virulence: retarded growth of Salmonella Typhimurium cells expressing type III secretion system 1. PLoS Pathog. 2011;7(7):e1002143. pmid:21829349
  16. 16. Milne-Davies B, Helbig C, Wimmi S, Cheng DWC, Paczia N, Diepold A. Life After Secretion-Yersinia enterocolitica Rapidly Toggles Effector Secretion and Can Resume Cell Division in Response to Changing External Conditions. Front Microbiol. 2019;10:2128. pmid:31572334
  17. 17. Bölin I, Portnoy DA, Wolf-Watz H. Expression of the temperature-inducible outer membrane proteins of yersiniae. Infect Immun. 1985;48(1):234–40. pmid:3980086
  18. 18. Böhme K, Steinmann R, Kortmann J, Seekircher S, Heroven AK, Berger E, et al. Concerted actions of a thermo-labile regulator and a unique intergenic RNA thermosensor control Yersinia virulence. PLoS Pathog. 2012;8(2):e1002518. pmid:22359501
  19. 19. Dewoody RS, Merritt PM, Marketon MM. Regulation of the Yersinia type III secretion system: traffic control. Front Cell Infect Microbiol. 2013;3:4. pmid:23390616
  20. 20. Hoe NP, Goguen JD. Temperature sensing in Yersinia pestis: translation of the LcrF activator protein is thermally regulated. J Bacteriol. 1993;175(24):7901–9. pmid:7504666
  21. 21. Wang H, Avican K, Fahlgren A, Erttmann SF, Nuss AM, Dersch P, et al. Increased plasmid copy number is essential for Yersinia T3SS function and virulence. Science. 2016;353(6298):492–5. pmid:27365311
  22. 22. Schneiders S, Hechard T, Edgren T, Avican K, Fällman M, Fahlgren A, et al. Spatiotemporal Variations in Growth Rate and Virulence Plasmid Copy Number during Yersinia pseudotuberculosis Infection. Infect Immun. 2021;89(4):e00710-20. pmid:33495272
  23. 23. Schott S, Scheuer R, Ermoli F, Glatter T, Evguenieva-Hackenberg E, Diepold A. A ParDE toxin-antitoxin system is responsible for the maintenance of the Yersinia virulence plasmid but not for type III secretion-associated growth inhibition. Front Cell Infect Microbiol. 2023;13:1166077. pmid:37228670
  24. 24. Villa L, García-Fernández A, Fortini D, Carattoli A. Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants. J Antimicrob Chemother. 2010;65(12):2518–29. pmid:20935300
  25. 25. Nordström K. Plasmid R1--replication and its control. Plasmid. 2006;55(1):1–26. pmid:16199086
  26. 26. Meynell E, Datta N. The relation of resistance transfer factors to the F-factor (sex-factor) of Escherichia coli K12. Genet Res. 1966;7(1):134–40. pmid:5324663
  27. 27. Datta N, Kontomichalou P. Penicillinase synthesis controlled by infectious R factors in Enterobacteriaceae. Nature. 1965;208(5007):239–41. pmid:5326330
  28. 28. Olsson JA, Paulsson J, Nordström K. Effect of the CopB auxiliary replication control system on stability of maintenance of Par(+) plasmid R1. J Bacteriol. 2004;186(1):207–11. pmid:14679240
  29. 29. Lopilato J, Bortner S, Beckwith J. Mutations in a new chromosomal gene of Escherichia coli K-12, pcnB, reduce plasmid copy number of pBR322 and its derivatives. Mol Gen Genet. 1986;205(2):285–90. pmid:3100913
  30. 30. Liu JD, Parkinson JS. Genetics and sequence analysis of the pcnB locus, an Escherichia coli gene involved in plasmid copy number control. J Bacteriol. 1989;171(3):1254–61. pmid:2537812
  31. 31. Sippel AE. Purification and characterization of adenosine triphosphate: ribonucleic acid adenyltransferase from Escherichia coli. Eur J Biochem. 1973;37(1):31–40. pmid:4580885
  32. 32. Cao GJ, Sarkar N. Identification of the gene for an Escherichia coli poly(A) polymerase. Proc Natl Acad Sci U S A. 1992;89(21):10380–4. pmid:1438224
  33. 33. Martin G, Keller W. Mutational analysis of mammalian poly(A) polymerase identifies a region for primer binding and catalytic domain, homologous to the family X polymerases, and to other nucleotidyltransferases. EMBO J. 1996;15(10):2593–603. pmid:8665867
  34. 34. Masters M, March JB, Oliver IR, Collins JF. A possible role for the pcnB gene product of Escherichia coli in modulating RNA: RNA interactions. Mol Gen Genet. 1990;220(2):341–4. pmid:1691435
  35. 35. Yue D, Maizels N, Weiner AM. CCA-adding enzymes and poly(A) polymerases are all members of the same nucleotidyltransferase superfamily: characterization of the CCA-adding enzyme from the archaeal hyperthermophile Sulfolobus shibatae. RNA. 1996;2(9):895–908. pmid:8809016
  36. 36. Jones GH. Acquisition of pcnB [poly(A) polymerase I] genes via horizontal transfer from the β, γ-Proteobacteria. Microb Genom. 2021;7(2):000508. pmid:33502308
  37. 37. Xu F, Cohen SN. RNA degradation in Escherichia coli regulated by 3’ adenylation and 5’ phosphorylation. Nature. 1995;374(6518):180–3. pmid:7533264
  38. 38. O’Hara EB, Chekanova JA, Ingle CA, Kushner ZR, Peters E, Kushner SR. Polyadenylylation helps regulate mRNA decay in Escherichia coli. Proc Natl Acad Sci U S A. 1995;92(6):1807–11. pmid:7534403
  39. 39. Hajnsdorf E, Braun F, Haugel-Nielsen J, Régnier P. Polyadenylylation destabilizes the rpsO mRNA of Escherichia coli. Proc Natl Acad Sci U S A. 1995;92(9):3973–7. pmid:7732015
  40. 40. Le Derout J, Folichon M, Briani F, Dehò G, Régnier P, Hajnsdorf E. Hfq affects the length and the frequency of short oligo(A) tails at the 3’ end of Escherichia coli rpsO mRNAs. Nucleic Acids Res. 2003;31(14):4017–23. pmid:12853618
  41. 41. Maes A, Gracia C, Innocenti N, Zhang K, Aurell E, Hajnsdorf E. Landscape of RNA polyadenylation in E. coli. Nucleic Acids Res. 2017;45(5):2746–56. pmid:28426097
  42. 42. Joanny G, Le Derout J, Bréchemier-Baey D, Labas V, Vinh J, Régnier P, et al. Polyadenylation of a functional mRNA controls gene expression in Escherichia coli. Nucleic Acids Res. 2007;35(8):2494–502. pmid:17395638
  43. 43. Reichenbach B, Maes A, Kalamorz F, Hajnsdorf E, Görke B. The small RNA GlmY acts upstream of the sRNA GlmZ in the activation of glmS expression and is subject to regulation by polyadenylation in Escherichia coli. Nucleic Acids Res. 2008;36(8):2570–80. pmid:18334534
  44. 44. Mohanty BK, Maples VF, Kushner SR. Polyadenylation helps regulate functional tRNA levels in Escherichia coli. Nucleic Acids Res. 2012;40(10):4589–603. pmid:22287637
  45. 45. Holmqvist E, Wagner EGH. Impact of bacterial sRNAs in stress responses. Biochem Soc Trans. 2017;45(6):1203–12. pmid:29101308
  46. 46. Sinha D, Matz LM, Cameron TA, De Lay NR. Poly(A) polymerase is required for RyhB sRNA stability and function in Escherichia coli. RNA. 2018;24(11):1496–511. pmid:30061117
  47. 47. Francis N, Laishram RS. Transgenesis of mammalian PABP reveals mRNA polyadenylation as a general stress response mechanism in bacteria. iScience. 2021;24(10):103119. pmid:34646982
  48. 48. Masters M, Colloms MD, Oliver IR, He L, Macnaughton EJ, Charters Y. The pcnB gene of Escherichia coli, which is required for ColE1 copy number maintenance, is dispensable. J Bacteriol. 1993;175(14):4405–13. pmid:8331071
  49. 49. Xu F, Lin-Chao S, Cohen SN. The Escherichia coli pcnB gene promotes adenylylation of antisense RNAI of ColE1-type plasmids in vivo and degradation of RNAI decay intermediates. Proc Natl Acad Sci U S A. 1993;90(14):6756–60. pmid:7688127
  50. 50. He L, Söderbom F, Wagner EG, Binnie U, Binns N, Masters M. PcnB is required for the rapid degradation of RNAI, the antisense RNA that controls the copy number of ColE1-related plasmids. Mol Microbiol. 1993;9(6):1131–42. pmid:7523833
  51. 51. Söderbom F, Binnie U, Masters M, Wagner EG. Regulation of plasmid R1 replication: PcnB and RNase E expedite the decay of the antisense RNA, CopA. Mol Microbiol. 1997;26(3):493–504. pmid:9402020
  52. 52. Kim JW, Bugata V, Cortés-Cortés G, Quevedo-Martínez G, Camps M. Mechanisms of Theta Plasmid Replication in Enterobacteria and Implications for Adaptation to Its Host. EcoSal Plus. 2020;9(1):10.1128/ecosalplus.ESP-0026–2019. pmid:33210586
  53. 53. Pienkoß S, Javadi S, Chaoprasid P, Holler M, Roßmanith J, Dersch P, et al. RNA Thermometer-coordinated Assembly of the Yersinia Injectisome. J Mol Biol. 2022;434(18):167667. pmid:35667470
  54. 54. Kupferberg LL, Higuchi K. Role of calcium ions in the stimulation of growth of virulent strains of Pasteurella pestis. J Bacteriol. 1958;76(1):120–1. pmid:13563403
  55. 55. Higuchi K, Kupferberg LL, Smith JL. Studies on the nutrition and physiology of Pasteurella pestis. III. Effects of calcium ions on the growth of virulent and avirulent strains of Pasteurella pestis. J Bacteriol. 1959;77(3):317–21. pmid:13641190
  56. 56. Rosqvist R, Magnusson KE, Wolf-Watz H. Target cell contact triggers expression and polarized transfer of Yersinia YopE cytotoxin into mammalian cells. EMBO J. 1994;13(4):964–72. pmid:8112310
  57. 57. Takacs CN, Wachter J, Xiang Y, Ren Z, Karaboja X, Scott M, et al. Polyploidy, regular patterning of genome copies, and unusual control of DNA partitioning in the Lyme disease spirochete. Nat Commun. 2022;13(1):7173. pmid:36450725
  58. 58. Erdmann N, Petroff T, Funnell BE. Intracellular localization of P1 ParB protein depends on ParA and parS. Proc Natl Acad Sci U S A. 1999;96(26):14905–10. pmid:10611311
  59. 59. Wang JD, Levin PA. Metabolism, cell growth and the bacterial cell cycle. Nat Rev Microbiol. 2009;7(11):822–7. pmid:19806155
  60. 60. Cooper S, Helmstetter CE. Chromosome replication and the division cycle of Escherichia coli B/r. J Mol Biol. 1968;31(3):519–40. pmid:4866337
  61. 61. Miller HK, Kwuan L, Schwiesow L, Bernick DL, Mettert E, Ramirez HA, et al. IscR is essential for Yersinia pseudotuberculosis type III secretion and virulence. PLoS Pathog. 2014;10(6):e1004194. pmid:24945271
  62. 62. Zhou P, She Y, Dong N, Li P, He H, Borio A, et al. Alpha-kinase 1 is a cytosolic innate immune receptor for bacterial ADP-heptose. Nature. 2018;561(7721):122–6. pmid:30111836
  63. 63. Orth K, Palmer LE, Bao ZQ, Stewart S, Rudolph AE, Bliska JB, et al. Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector. Science. 1999;285(5435):1920–3. pmid:10489373
  64. 64. Orth K, Xu Z, Mudgett MB, Bao ZQ, Palmer LE, Bliska JB, et al. Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease. Science. 2000;290(5496):1594–7. pmid:11090361
  65. 65. Riley G, Toma S. Detection of pathogenic Yersinia enterocolitica by using congo red-magnesium oxalate agar medium. J Clin Microbiol. 1989;27(1):213–4. pmid:2913030
  66. 66. Raynal LC, Carpousis AJ. Poly(A) polymerase I of Escherichia coli: characterization of the catalytic domain, an RNA binding site and regions for the interaction with proteins involved in mRNA degradation. Mol Microbiol. 1999;32(4):765–75. pmid:10361280
  67. 67. Toh Y, Takeshita D, Nagaike T, Numata T, Tomita K. Mechanism for the alteration of the substrate specificities of template-independent RNA polymerases. Structure. 2011;19(2):232–43. pmid:21300291
  68. 68. Million-Weaver S, Alexander DL, Allen JM, Camps M. Quantifying plasmid copy number to investigate plasmid dosage effects associated with directed protein evolution. Methods Mol Biol. 2012;834:33–48. pmid:22144351
  69. 69. Amann E, Ochs B, Abel KJ. Tightly regulated tac promoter vectors useful for the expression of unfused and fused proteins in Escherichia coli. Gene. 1988;69(2):301–15. pmid:3069586
  70. 70. Lacatena RM, Cesareni G. Base pairing of RNA I with its complementary sequence in the primer precursor inhibits ColE1 replication. Nature. 1981;294(5842):623–6. pmid:6171736
  71. 71. Brantl S. Plasmid Replication Control by Antisense RNAs. Microbiol Spectr. 2014;2(4):PLAS-0001-2013. pmid:26104196
  72. 72. Selzer G, Som T, Itoh T, Tomizawa J. The origin of replication of plasmid p15A and comparative studies on the nucleotide sequences around the origin of related plasmids. Cell. 1983;32(1):119–29. pmid:6186390
  73. 73. Uga H, Matsunaga F, Wada C. Regulation of DNA replication by iterons: an interaction between the ori2 and incC regions mediated by RepE-bound iterons inhibits DNA replication of mini-F plasmid in Escherichia coli. EMBO J. 1999;18(13):3856–67. pmid:10393200
  74. 74. Jurėnas D, Fraikin N, Goormaghtigh F, De Bruyn P, Vandervelde A, Zedek S, et al. Bistable Expression of a Toxin-Antitoxin System Located in a Cryptic Prophage of Escherichia coli O157:H7. mBio. 2021;12(6):e0294721. pmid:34844426
  75. 75. Mecsas J, Bilis I, Falkow S. Identification of attenuated Yersinia pseudotuberculosis strains and characterization of an orogastric infection in BALB/c mice on day 5 postinfection by signature-tagged mutagenesis. Infect Immun. 2001;69(5):2779–87. pmid:11292689
  76. 76. de Jong MF, Liu Z, Chen D, Alto NM. Shigella flexneri suppresses NF-κB activation by inhibiting linear ubiquitin chain ligation. Nat Microbiol. 2016;1(7):16084. pmid:27572974
  77. 77. Spickler C, Mackie GA. Action of RNase II and polynucleotide phosphorylase against RNAs containing stem-loops of defined structure. J Bacteriol. 2000;182(9):2422–7. pmid:10762241
  78. 78. Blum E, Carpousis AJ, Higgins CF. Polyadenylation promotes degradation of 3’-structured RNA by the Escherichia coli mRNA degradosome in vitro. J Biol Chem. 1999;274(7):4009–16. pmid:9933592
  79. 79. Coburn GA, Miao X, Briant DJ, Mackie GA. Reconstitution of a minimal RNA degradosome demonstrates functional coordination between a 3’ exonuclease and a DEAD-box RNA helicase. Genes Dev. 1999;13(19):2594–603. pmid:10521403
  80. 80. Marujo PE, Hajnsdorf E, Le Derout J, Andrade R, Arraiano CM, Régnier P. RNase II removes the oligo(A) tails that destabilize the rpsO mRNA of Escherichia coli. RNA. 2000;6(8):1185–93. pmid:10943897
  81. 81. Rosenzweig JA, Chromy B, Echeverry A, Yang J, Adkins B, Plano GV, et al. Polynucleotide phosphorylase independently controls virulence factor expression levels and export in Yersinia spp. FEMS Microbiol Lett. 2007;270(2):255–64. pmid:17391372
  82. 82. Rosenzweig JA, Weltman G, Plano GV, Schesser K. Modulation of Yersinia type three secretion system by the S1 domain of polynucleotide phosphorylase. J Biol Chem. 2005;280(1):156–63. pmid:15509583
  83. 83. Knittel V, Vollmer I, Volk M, Dersch P. Discovering RNA-Based Regulatory Systems for Yersinia Virulence. Front Cell Infect Microbiol. 2018;8:378. pmid:30460205
  84. 84. Mohanty BK, Maples VF, Kushner SR. The Sm-like protein Hfq regulates polyadenylation dependent mRNA decay in Escherichia coli. Mol Microbiol. 2004;54(4):905–20. pmid:15522076
  85. 85. Werbowy O, Boratynski R, Dekowska A, Kaczorowski T. Genetic analysis of maintenance of pEC156, a naturally occurring Escherichia coli plasmid that carries genes of the EcoVIII restriction-modification system. Plasmid. 2015;77:39–50. pmid:25500017
  86. 86. Rozwandowicz M, Brouwer MSM, Fischer J, Wagenaar JA, Gonzalez-Zorn B, Guerra B, et al. Plasmids carrying antimicrobial resistance genes in Enterobacteriaceae. J Antimicrob Chemother. 2018;73(5):1121–37. pmid:29370371
  87. 87. Francis N, Behera MR, Natarajan K, Laishram RS. Tyrosine phosphorylation controlled poly(A) polymerase I activity regulates general stress response in bacteria. Life Sci Alliance. 2023;6(3):e202101148. pmid:36535710
  88. 88. Ottoz DSM, Berchowitz LE. The role of disorder in RNA binding affinity and specificity. Open Biol. 2020;10(12):200328. pmid:33352065
  89. 89. Milton DL, Norqvist A, Wolf-Watz H. Cloning of a metalloprotease gene involved in the virulence mechanism of Vibrio anguillarum. J Bacteriol. 1992;174(22):7235–44. pmid:1429449
  90. 90. Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol. 2006;2:2006.0008. pmid:16738554
  91. 91. Sidik S, Kottwitz H, Benjamin J, Ryu J, Jarrar A, Garduno R, et al. A Shigella flexneri virulence plasmid encoded factor controls production of outer membrane vesicles. G3 (Bethesda). 2014;4(12):2493–503. pmid:25378474
  92. 92. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A. 2000;97(12):6640–5. pmid:10829079
  93. 93. Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114–20. pmid:24695404
  94. 94. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754–60. pmid:19451168
  95. 95. Johnson SL, Daligault HE, Davenport KW, Jaissle J, Frey KG, Ladner JT, et al. Thirty-Two Complete Genome Assemblies of Nine Yersinia Species, Including Y. pestis, Y. pseudotuberculosis, and Y. enterocolitica. Genome Announc. 2015;3(2). pmid:25931590
  96. 96. Zoubeidi A, Schwiesow L, Auerbuch V, Lam HN. Complete Genome Assembly of Yersinia pseudotuberculosis IP2666pIB1. Microbiol Resour Announc. 2019;8(7):e01592-18. pmid:30801065
  97. 97. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25(16):2078–9. pmid:19505943
  98. 98. Auwera GAV, O’Connor BD. Genomics in the cloud: using Docker, GATK, and WDL in Terra. First ed. Sebastopol, CA: O’Reilly Media; 2020.
  99. 99. Hechard T, Wang H. Determination of Growth Rate and Virulence Plasmid Copy Number During Yersinia pseudotuberculosis Infection Using Droplet Digital PCR. Methods Mol Biol. 2023;2674:101–15. pmid:37258963
  100. 100. Paintdakhi A, Parry B, Campos M, Irnov I, Elf J, Surovtsev I, et al. Oufti: an integrated software package for high-accuracy, high-throughput quantitative microscopy analysis. Mol Microbiol. 2016;99(4):767–77. pmid:26538279
  101. 101. Campos M, Govers SK, Irnov I, Dobihal GS, Cornet F, Jacobs-Wagner C. Genomewide phenotypic analysis of growth, cell morphogenesis, and cell cycle events in Escherichia coli. Mol Syst Biol. 2018;14(6):e7573. pmid:29941428
  102. 102. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676–82. pmid:22743772
  103. 103. Ovesný M, Křížek P, Borkovec J, Svindrych Z, Hagen GM. ThunderSTORM: a comprehensive ImageJ plug-in for PALM and STORM data analysis and super-resolution imaging. Bioinformatics. 2014;30(16):2389–90. pmid:24771516
  104. 104. Otsu N. A Threshold Selection Method from Gray-Level Histograms. IEEE Trans Syst, Man, Cybern. 1979;9(1):62–6.
  105. 105. Kwuan L, Adams W, Auerbuch V. Impact of host membrane pore formation by the Yersinia pseudotuberculosis type III secretion system on the macrophage innate immune response. Infect Immun. 2013;81(3):905–14. pmid:23297383
  106. 106. Kim D, Paggi JM, Park C, Bennett C, Salzberg SL. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019;37(8):907–15. pmid:31375807
  107. 107. Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30(7):923–30. pmid:24227677
  108. 108. Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139–40. pmid:19910308
  109. 109. Metsalu T, Vilo J. ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap. Nucleic Acids Res. 2015;43(W1):W566-70. pmid:25969447
  110. 110. Balada-Llasat J-M, Mecsas J. Yersinia has a tropism for B and T cell zones of lymph nodes that is independent of the type III secretion system. PLoS Pathog. 2006;2(9):e86. pmid:16948531